A structured controlled vocabulary of phenotypes of the slime-mould Dictyostelium discoideum.
Deviation from the normal, usual, or expected spore color.
Deviation from the normal, usual, or expected morphology of the standing slug (finger).
Increase in relative or proportionate length of the slug.
Decrease in relative or proportionate dimensions of the slug.
Deviation from the normal, usual, or expected events during autophagy, a cellular catabolic process when cells digest or remodel their parts under stress.
Increase in extent, amount, or degree of autophagy, a cellular catabolic process when cells digest or remodel their parts under stress.
Reduction in extent, amount, or degree of autophagy, a cellular catabolic process when cells digest or remodel their parts under stress.
Deviation from the normal, usual, or expected events during co-transciptional gene silencing by RNA.
aberrant small RNA-mediated co-transcriptional gene silencing
aberrant co-transcriptional gene silencing by RNA interference machinery
Deviation from the normal, usual, or expected morphology of the fruiting body.
Complete inability for co-transciptional gene silencing by RNA.
abolished small RNA-mediated co-transcriptional gene silencing
abolished co-transcriptional gene silencing by RNA interference machinery
Reduction in level of modification of co-transciptional gene silencing by RNA.
decreased small RNA-mediated co-transcriptional gene silencing
decreased co-transcriptional gene silencing by RNA interference machinery
Deviation from the normal, usual, or expected events during pre-miRNA processing.
Complete inability for pre-miRNA processing.
Increase in level of pre-miRNA processing.
Reduction in level of pre-miRNA processing.
Deviation from the normal, usual, or expected events during transitive RNA interference.
Complete inability for transitive RNA interference.
abolished culmination involved in sorocarp development
OBSOLETE Deviation from the normal, usual, or expected events during RNA interference.
OBSOLETE Complete inability for RNA interference.
Deviation from the normal, usual, or expected events during production of siRNA involved in RNA interference.
aberrant production of siRNA involved in RNA interference
aberrant production of siRNA involved in RNAi
Complete inability for production of siRNA involved in RNA interference.
abolished production of siRNA involved in RNA interference
abolished production of siRNA involved in RNAi
abolished regulation of siRNA processing
Development cannot progress past the mound stage.
development arrests at tight aggregate stage
development arrests at tight mound stage
Complete inability for phagosome reneutralization.
Complete inability for stalk development.
Increase in extent, amount, or degree of resistance to N-Phenylthiourea.
increased resistance to N-Phenylthiourea
Complete inability to form slugs during development.
abolished slug development involved in sorocarp development
OBSOLETE. Complete inability for rendocytosis.
Increase in extent, amount, or degree of spore formation.
Deviation from the normal, usual, or expected events during secretion of a substance.
Deviation from the normal, usual, or expected events during contractile vacuole discharge.
Complete inability for contractile vacuole discharge.
Increase in extend, amount, or degree of the number of tips.
Reduction in extent, amount, or degree of contractile vacuole discharge.
Increase in extent, amount, or degree of contractile vacuole discharge.
Deviation from the normal, usual, or expected events during plasma membrane organization.
aberrant plasma membrane organization and biogenesis
Deviation from the normal, usual, or expected events during the response to a chemical.
Deviation from the normal, usual, or expected events during the response to N-Phenylthiourea.
Deviation from the normal, usual, or expected events during membrane ruffling.
Reduction in extent, amount, or degree of membrane ruffling.
OBSLOTETE. Deviation from the normal, usual, or expected events during SDF production.
Deviation from the normal, usual, or expected events during phosphatidylinositol metabolism.
aberrant phosphatidylinositol metabolic process
aberrant phosphatidylinositol metabolism
Deviation from the normal, usual, or expected events during phosphatidylinositol synthesis.
aberrant phosphatidylinositol biosynthetic process
Reduction in extent, amount, or degree of phosphatidylinositol synthesis.
decreased phosphatidylinositol biosynthetic process
decreased phosphatidylinositol synthesis
Increase in extent, amount, or degree of phosphatidylinositol synthesis.
increased phosphatidylinositol biosynthetic process
increased phosphatidylinositol synthesis
Complete inability for the production of phosphatidylinositol.
abolished phosphatidylinositol biosynthetic process
abolished phosphatidylinositol synthesis
Complete inability to respond to cellular hypo-osmotic stress.
abolished cellular response to hypotonic stress
abolished cellular response to hypo-osmotic stress
Reduction in extent, amount, or degree of the cellular response to hypo-osmotic stress.
decreased cellular response to hypo-osmotic stress
decreased cellular response to hypotonic stress
Increase in extent, amount, or degree of the cellular response to hypo-osmotic stress.
increased cellular response to hypo-osmotic stress
increased cellular response to hypotonic stress
Decrease in relative or proportionate dimensions of the contractile vacuole.
Reduction in relative or proportionate dimensions of the fruiting body.
Deviation from the normal, usual, or expected events during endocytosis.
OBSOLETE. Was not defined before obsoletion.
Deviation from the normal, usual, or expected events during differentiation of prestalk A cells.
aberrant prestalk A cell differentiation
Reduction in extent, amount, or degree of chemotaxis rate during the locomotory response to a chemical concentration gradient.
Deviation from the normal, usual, or expected events during localization of a protein to the nucleolus.
aberrant protein localization to nucleolus
Complete inability to localize a protein to the nucleolus.
abolished protein localization to nucleolus
Reduction in amount or accumulation of a protein to the nucleolus.
decreased protein localization to nucleolus
Increase in amount or accumulation of a protein at the nucleolus.
increased protein localization to nucleolus
Increase in amount or accumulation of cytosolic glucose.
Increase in extent, amount, or degree of cell-cell adhesion.
Complete inability to localize to a cellular compartment or structure.
Use for mutated gene products that do not localize to their typical cellular compartment compared to the wild type gene product.
Increase in relative or proportionate dimensions of the mound.
aberrant negative regulation of aggregate size
Reduction in amount or accumulation at a certain cellular location.
Increase in amount or accumulation at a certain cellular location.
Deviation from the normal, usual, or expected events during substrate adhesion-dependent cell spreading.
aberrant cell spreading during cell substrate adhesion
aberrant substrate adhesion dependent cell spreading
aberrant substrate adhesion-dependent cell spreading
Increase in extent, amount, or degree of cell motility.
Complete inability for substrate adhesion-dependent cell spreading.
abolished cell spreading during cell substrate adhesion
abolished substrate adhesion dependent cell spreading
abolished substrate adhesion-dependent cell spreading
Reduction in extent, amount, or degree of substrate adhesion-dependent cell spreading.
decreased cell spreading during cell substrate adhesion
decreased substrate adhesion dependent cell spreading
reduced cell spreading during cell substrate adhesion
reduced substrate adhesion dependent cell spreading
reduced substrate adhesion-dependent cell spreading
decreased substrate adhesion-dependent cell spreading
Increase in extent, amount, or degree of substrate adhesion-dependent cell spreading.
increased cell spreading during cell substrate adhesion
increased substrate adhesion dependent cell spreading
increased substrate adhesion-dependent cell spreading
Deviation from the normal, usual, or expected events during cell-cell recognition.
Reduction in extent, amount or accumulation of cytosolic glucose.
Deviation from the normal, usual, or expected events during cell-cell self recognition.
Reduction in extent, amount, or degree of cGMP-mediated signaling.
OBSOLETE. Increase in extent, amount, or degree of cAMP pulse in response to cAMP.
obsolete increased cAMP-induced cAMP pulse
Complete inability to perform cell-cell self recognition.
Increase in extent, amount, or degree of cGMP-mediated signaling.
Deviation from the normal, usual, or expected social cooperation during aggregation.
aberrant socially cooperative aggregation
aberrant socially cooperative development
Reduction in social cooperation during development.
Involves cheating during development; cheaters make more spores than their normal share in chimeras.
decreased socially cooperative development
Increase in extent, amount, or degree of resistance to the flavonoid naringenin.
OBSOLETE. Reduction in extent, amount, or degree of cAMP pulse in response to cAMP.
obsolete decreased cAMP-induced cAMP pulse
OBSOLETE. Increase in extent, amount, or degree of secretion of counting factor (CF).
obsolete increased secretion of counting factor (CF)
Increase in amount or accumulation of actin filament bundle assembly.
increased actin filament bundle assembly
OBSOLETE. Increase in extent, amount, or degree ABP120 protein level.
Increase in extent, amount, or degree of assembly of myosin II.
OBSOLETE. Reduction in extent, amount or accumulation of ABP120 level.
Reduction in extent, amount, or degree of myosin II assembly.
Reduction in amount or accumulation of actin filament bundle assembly.
decreased actin filament bundle assembly
Reduction in extent, amount, or degree of cell-cell adhesion.
Reduction in extent, amount, or degree of gamete fusion during macrocyst formation.
decreased conjugation with cellular fusion
Reduction in amount or accumulation of the slime trail, acellular material from the surface sheath left behind the migratory slug.
Reduction in extent, amount, or degree of chemotaxis towards a decreasing chemical concentration.
No phenotypic difference has been reported compared to wild type.
Increase in extent, amount, or degree of chemotaxis towards a decreasing chemical concentration.
Complete inability for negative chemotaxis.
Deviation from the normal, usual, or expected chemorepellant activity.
GO:0045499; Chemorepellant activity is the counter part_of DDPHENO:0001225 negative chemotaxis.
Reduction in extent, amount, or degree of cell motility.
Deviation from the normal, usual, or expected events during cytokinesis.
Complete inability for chemorepellant activity.
Deviation from the normal, usual, or expected events during actin filament organization.
Increase in extent, amount, or degree of chemorepellant activity.
Reduction in extent, amount, or degree of chemorepellant activity.
Deviation from the normal, usual, or expected events during sorocarp development.
merged_development hypersensitive to ammonia
Development cannot progress past the tipped mound stage.
development arrests at tipped aggregate stage
development arrests at tipped mound stage
Late onset or slower progression through aggregation.
delayed aggregation during fruiting body development
delayed aggregation involved in sorocarp development
Late onset or slower progression through development of tipped mound.
delayed sorocarp development of tipped mound
Reduction in relative or proportionate dimensions of the mound.
decreased positive regulation of aggregate size
Development cannot progress past the loose mound stage.
development arrests at loose aggregate stage
development arrests at loose aggregate stage in the presence of EGTA
development arrests at loose aggregate stage in the presence of TMB-8
merged_development arrests at loose aggregate stage in the presence of lithium
development arrests at loose mound stage
Increase in relative or proportionate dimensions of the slug.
Late onset or slower progression through culmination.
delayed culmination involved in sorocarp development
Late onset or slower progression through development.
merged_delayed development in the presence of gossypol
merged_delayed development in the presence of lithium
Deviation from the normal, usual, or expected morphology of the spore.
OBSOLETE Deviation from the normal, usual, or expected events during the regulation of chemorepellant activity.
obsolete aberrant regulation of chemorepellant activity
Reduction in relative or proportionate dimensions of the sorus.
Early onset or faster progression through development.
Development cannot progress past the migratory slug stage during development.
development arrests at migratory slug stage
Increase in extent, amount, or degree of prestalk cell differentiation.
Increase in extent, amount, or degree of differentiation into prespore cells.
Increase in extent, amount, or degree of cell proliferation.
increased growth rate on bacterial plates
Early onset or faster progression of release from spore dormancy.
Reduction in extent, amount, or degree of differentiation into prespore cells.
Increase in extent, amount, or degree of differentiation into prestalk O cells.
increased prestalk O cell differentiation
OBSOLETE Deviation from the normal, usual, or expected events during the positive regulation of chemorepellant activity.
obsolete aberrant positive regulation of chemorepellant activity
Early onset or faster progression through development of tipped mound.
precocious sorocarp development of tipped mound
Complete inability for slugs to migrate.
Reduction in extent, amount, or degree of astral microtubules.
Reduction in extent or length of astral microtubules.
Decreased tolerance of the normal, usual, or expected events towards nocodazole.
Deviation from the normal, usual, or expected events during cell-substrate adhesion.
Reduction in extent, amount, or degree of phagocytosis.
OBSOLETE Deviation from the normal, usual, or expected events during the negative regulation of chemorepellant activity.
obsolete aberrant negative regulation of chemorepellant activity
Reduction in extent, amount, or degree of differentiation into prestalk cells.
Complete inability for differentiation of prestalk O cells.
abolished prestalk O cell differentiation
Complete inability for DIF biosynthesis.
abolished differentiation inducing factor 1 biosynthesis
Reduction in extent, amount, or degree of differentiation into stalk cells.
OBSOLETE. Increase in extent, amount, or degree of kinase a activity.
obsolete increased protein kinase A activity
OBSOLETE. Increase in extent, amount, or degree of GTP-gamma-S-stimulated guanylyl cyclase activity.
obsolete increased GTP-gamma-S-stimulated guanylyl cyclase activity
OBSOLETE Deviation from the normal, usual, or expected events during the activation of adenylate cyclase.
Replaced "defective in activation of adenylate cyclase (ACA)" with "aberrant activation of adenylate cyclase (ACA)"; annotations should be changed to "decreased" or "abolished" activation of adenylate cyclase. PG 10-11-2006.
obsolete aberrant activation of adenylate cyclase activity
OBSOLETE. Reduction in extent, amount, or degree of GTP-gamma-S-stimulated guanylyl cyclase activity.
obsolete decreased GTP-gamma-S-stimulated guanylyl cyclase activity
OBSOLETE. Reduction in extent, amount, or degree of glycogen synthase kinase 3 activity.
obsolete decreased glycogen synthase kinase 3 activity
Quantitative increase in microtubule organizing centers.
increased number of microtubule organizing center
OBSOLETE. Reduction in extent, amount or accumulation of extracellular counting factor component level.
obsolete decreased extracellular counting factor component(s) level
OBSOLETE. Reduction in extent, amount or accumulation of extracellular CF50 level.
obsolete decreased extracellular CF50 level
Early onset or faster progression through aggregation.
precocious aggregation during fruiting body development
precocious aggregation involved in sorocarp development
Increase in relative or proportionate length of the standing slug.
Decrease in relative or proportionate width of the standing slug.
Deviation from the normal, usual, or expected events during the cellular response to osmotic stress.
aberrant cellular response to osmotic stress
Late onset or slower progression through slug development.
delayed slug development involved in sorocarp development
Deviation from the normal, usual, or expected events during the cellular response to nitrogen starvation.
aberrant cellular response to nitrogen starvation
Deviation from the normal, usual, or expected events during macroautophagy.
Increase in extent, amount, or degree of cell-substrate adhesion.
Early onset or faster progression through spore formation.
Decreased tolerance of the normal, usual, or expected events in spores towards hydrogen peroxide.
decreased spore resistance to hydrogen peroxide
Deviation from the normal, usual, or expected morphology of the spore coat.
Deviation from the normal, usual, or expected events during the response to light.
Deviation from the normal, usual, or expected events during the response to temperature changes.
Reduction in extent, amount, or degree of slug migration.
Increase in extent, amount, or degree of differentiation into prestalk A cells.
increased prestalk A cell differentiation
OBSOLETE Complete inability of the regulation of chemorepellant activity.
obsolete abolished regulation of chemorepellant activity
OBSOLETE Complete inability of the positive regulation of chemorepellant activity.
obsolete abolished positive regulation of chemorepellant activity
OBSOLETE Complete inability of the negative regulation of chemorepellant activity.
obsolete abolished negative regulation of chemorepellant activity
Deviation from the normal, usual, or expected morphology of the endosome.
Increase in extent, amount, or degree of cell death.
Reduction in extent, amount, or degree of release from spore dormancy.
Deviation from the normal, usual, or expected organization and biogenesis of the contractile vacuole.
aberrant contractile vacuole organization
Deviation from the normal, usual, or expected events during mitosis.
OBSOLETE. Increase in extent, amount, or degree of aneuploidy.
Deviation from the normal, usual, or expected morphology of a cell.
Reduction in extent, amount, or degree of cell death.
OBSOLETE. Deviation from the normal, usual, or expected events during DNA-mediated transformation.
obsolete aberrant DNA mediated transformation
OBSOLETE. Reduction in extent, amount or degree of DNA mediated transformation.
obsolete decreased DNA mediated transformation
OBSOLETE. Increase in extent, amount, or degree of DNA mediated transformation.
obsolete increased DNA mediated transformation
OBSOLETE. Complete inability for DNA-mediated transformation.
obsolete abolished DNA mediated transformation
Deviation from the normal, usual, or expected events during DNA repair.
Deviation from the normal, usual, or expected events during single-strand break DNA repair.
Deviation from the normal, usual, or expected events during double-strand break DNA repair.
Reduction in extent, amount, or degree of double strand break DNA repair.
Reduction in extent, amount, or degree of single-strand break repair of DNA.
Complete inability for double strand break DNA repair.
Complete inability for single-strand break repair of DNA.
Increased tolerance of the normal, usual, or expected events in double-strand break repair.
Increased tolerance of the normal, usual, or expected events in single-strand break repair of DNA.
Deviation from the normal, usual, or expected events during regulation of the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
aberrant regulation of mitochondrial membrane potential
Deviation from the normal, usual, or expected events during positive regulation of the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
aberrant positive regulation of mitochondrial membrane potential
Deviation from the normal, usual, or expected events during negative regulation of the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
aberrant negative regulation of mitochondrial membrane potential
Deviation from the normal, usual, or expected events during the locomotory response guided by increasing chemical concentration of calcium.
aberrant cell motility in response to calcium ion
OBSOLETE. Deviation from the normal, usual, or expected events during potassium-dependent chemotaxis to cAMP.
obsolete aberrant potassium-dependent chemotaxis to cAMP
OBSOLETE. Complete inability for potassium-dependent chemotaxis to cAMP.
obsolete abolished potassium-dependent chemotaxis to cAMP
Complete inability for chemotaxis in response to calcium.
abolished cell motility in response to calcium ion
Deviation from the normal, usual, or expected events during defence response to bacterium.
aberrant infection rate by pathogenic bacterium
Pathogenic bacteria are defined as being pathogens for humans, though in the any specific study a strain or species less virulent for humans may have been used.
Reduction in extent, amount, or degree of cell migration to prestalk region during the slug stage.
decreased cell migration to prestalk region
OBSOLETE. Complete inability for prestalk cell differentiation in response to DIF-1.
obsolete abolished prestalk cell differentiation in response to DIF-1
Reduction in extent, amount, or degree of differentiation into prestalk O cells.
decreased prestalk O cell differentiation
Deviation from the normal, usual, or expected morphology of the nucleus.
Deviation from the normal, usual, or expected events during cell motility.
Deviation from the normal, usual, or expected events during myosin II organization.
aberrant myosin II filament organization
Increase in relative or proportionate dimensions of the basal disc.
OBSOLETE. Quantitative increase in tubular mitochondria. In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete increased number of tubular mitochondria
OBSOLETE. Reduction in extent, amount or accumulation of SDF production.
OBSOLETE. Complete inability for SDF production.
OBSOLETE. Increased tolerance of the normal, usual, or expected events in the presence of DNA damaging agents.
decreased sensitivity to DNA-damaging agents
obsolete increased resistance to DNA-damaging agents
Increase in extent, amount, or degree of the def defence ense response to bacterium.
Reduction in extent, amount, or degree for defence response to bacterium.
Deviation from the normal, usual, or expected events defence response to fungus.
obsolete aberrant infection rate by a yeast
Increase in extent, amount, or degree of the defence response to fungus.
Reduction in extent, amount, or degree for defence response to fungus.
Deviation from the normal, usual, or expected events during defence response to Gram-positive bacterium, often after infection.
aberrant defence response to pathogenic Gram-positive bacterium
aberrant defence response to Gram-positive bacterium
Increase in extent, amount, or degree of the defence response to Gram-positive bacterium, often after infection.
increased defence response to pathogenic Gram-positive bacterium
increased defence response to Gram-positive bacterium
Reduction in extent, amount, or degree for defence response to Gram-positive bacterium, often after infection.
decreased defence response to pathogenic Gram-positive bacterium
decreased defence response to Gram-positive bacterium
Deviation from the normal, usual, or expected events defence response to Gram-negative bacterium, often after infection.
aberrant defence response to pathogenic Gram-negative bacterium
aberrant defence response to Gram-negative bacterium
Increase in extent, amount, or degree of the defence response to Gram-negative bacterium, often after infection.
increased defence response to pathogenic Gram-negative bacterium
increased defence response to Gram-negative bacterium
Reduction in extent, amount, or degree of the defence response to Gram-negative bacterium, often after infection.
decreased defence response to pathogenic Gram-negative bacterium
decreased defence response to Gram-negative bacterium
Complete inability for defence response to Gram-positive bacterium, often after infection.
abolished defence response to pathogenic Gram-positive bacterium
abolished defence response to Gram-positive bacterium
Complete inability for defence response to Gram-negative bacterium, often after infection.
abolished defence response to pathogenic Gram-negative bacterium
abolished defence response to Gram-negative bacterium
obsolete decreased infection rate by Mycobacterium marinum
obsolete increased infection rate by Mycobacterium marinum
Deviation from the normal, usual, or expected binding of a protein.
A reduction in extent, amount, or degree of binding to a protein.
Increased in extent, amount, or degree of binding a protein.
Deviation from the normal, usual, or expected binding a lipid.
Reduction in extent, amount, or degree of gene expression.
merged_decreased expression of aggregation genes
merged_decreased expression of prespore genes
merged_decreased expression of prestalk genes
merged_decreased expression of spore genes
Increase in extent, amount, or degree of gene expression.
merged_increased expression of post-aggregative genes
merged_increased expression of prespore genes
merged_increased expression of prestalk genes
Complete inability for cells to proliferate.
Increase in extent, amount, or degree of membrane ruffling.
OBSOLETE. Complete inability for down-regulation of growth phase genes.
obsolete abolished down-regulation of growth phase genes
Deviation from the normal, usual, or expected cell migration to the prestalk region.
aberrant cell migration to prestalk region
OBSOLETE. Complete inability for SDF-1 production.
OBSOLETE. Complete inability for SDF-2 production.
OBSOLETE. Reduction in extent, amount or accumulation of SDF-1 production.
OBSOLETE. Reduction in extent, amount or accumulation of SDF-2 production.
Deviation from the normal, usual, or expected during MPBD biosynthesis, a polyketide.
aberrant 4-methyl5-pentylbenzene-1,3 diol production
Complete inability for the biosynthesis of MPBD, a polyketide.
abolished 4-methyl5-pentylbenzene-1,3-diol production
Reduction in extent, amount, or degree of MPBD biosynthesis, a polyketide.
decreased 4-methyl5-pentylbenzene-1,3 diol production
Deviation from the normal, usual, or expected during the polyketide metabolic process.
aberrant response to 4-methyl5-pentylbenzene-1,3 diol (MPBD)
Complete inability for polyketide metabolic process.
abolished response to 4-methyl5-pentylbenzene-1,3 diol (MPBD)
OBSOLETE. Deviation from the normal, usual, or expected events during response to SDF-1.
OBSOLETE. Complete inability for response to SDF-1.
Complete inability to form a tipped mound during development.
abolished sorocarp development of tipped mound
Deviation from the normal, usual, or expected binding a polysaccharide.
Deviation from the normal, usual, or expected binding of cellulose.
A reduction in extent, amount, or degree of binding to cellulose.
Deviation from the normal, usual, or expected binding of a cyclic nucleotide.
A reduction in extent, amount, or degree of binding to a lipid.
Deviation from the normal, usual, or expected binding a small molecule.
Small molecules include monosaccharides but exclude disaccharides and polysaccharides; includes organic cyclic compounds and single amino acids.
Complete absence of small molecule binding.
A reduction in extent, amount, or degree of binding to a small molecule.
Deviation from the normal, usual, or expected binding to folic acid.
A reduction in extent, amount, or degree of binding to folic acid.
Increased in extent, amount, or degree of binding to folic acid.
OBSOLETE. Deviation from the normal, usual, or expected events during the locomotory response to an electrical field.
Obsolete Reduction in extent, amount, or degree of electrotaxis rate during the locomotory response to an electrical field.
OBSOLETE. Increase in extent, amount, or degree of electrotaxis rate during the locomotory response to an electrical field.
OBSOLETE. Complete inability for electrotaxis in response to an electrical field.
OBSOLETE. Deviation from the normal, usual, or expected events during response to SDF-2.
OBSOLETE. Complete inability for response to SDF-2.
OBSOLETE. Deviation from the normal, usual, or expected plasma membrane organization during endocytosis.
obsolete aberrant membrane organization during endocytosis
Decrease from the normal, usual, or expected plasma membrane organization.
OBSOLETE Complete inability for activation of GTPase activity.
obsolete abolished activation of GTPase activity
OBSOLETE Reduction in extent, amount, or degree of activation GTPase activity.
obsolete decreased activation of GTPase activity
OBSOLETE Increase in extent, amount, or degree of activation of GTPase activity.
obsolete increased activation of GTPase activity
Reduction in extent, amount, or degree of protein kinase activity.
Complete absence of protein kinase activity.
Increase in extent, amount, or degree of protein kinase activity.
Deviation from the normal, usual, or expected events during calcium signaling.
Deviation from the normal, usual, or expected events during macropinocytosis.
Complete inability to perform macropinocytosis.
Reduction in extent, amount, or degree of macropinocytosis.
Deviation from the normal, usual, or expected events during endosomal transport.
Deviation from the normal, usual, or expected events during endocytic recycling.
aberrant retrograde transport of endocytic vesicles
Complete inability of endocytic recycling.
abolished retrograde transport of endocytic vesicles
Reduction in extent, amount, or degree of endocytic recycling.
decreased retrograde transport of endocytic vesicles
Increase in extent, amount, or degree of endocytic recycling.
increased retrograde transport of endocytic vesicles
Deviation from the normal, usual, or expected events during the response to cAMP.
Increase in extent, amount, or degree of response to cAMP.
Deviation from the normal, usual, or expected events during the response to nocodazole.
Increase in extent, amount, or degree of resistance to nocodazole.
Increase in extent, amount, or degree of macropinocytosis.
Deviation from the normal, usual, or expected expression of prestalk genes.
aberrant prestalk cell specific gene expression
Early onset or faster progression of prestalk cell specific gene expression.
precocious prestalk cell specific gene expression
OBSOLETE. Prestalk gene expression occurring in an abnormal position or in an unusual manner or form.
obsolete mislocalized prestalk gene expression
Late onset or slower progression of prestalk cell specific gene expression.
delayed prestalk cell specific gene expression
Reduction in extent, amount, or degree of prestalk cell specific gene expression.
decreased prestalk cell specific gene expression
Deviation from the normal, usual, or expected prespore cell specific gene expression.
aberrant prespore cell specific gene expression
Reduction in extent, amount, or degree of prespore cell specific gene expression.
decreased prespore cell specific gene expression
Late onset or slower progression of prespore cell specific gene expression.
delayed prespore cell specific gene expression
Increase in extent, amount, or degree of formation of filopodia.
Reduction in extent, amount, or degree of suppression or retraction of lateral pseudopods.
decreased lateral pseudopodium retraction
Reduction in relative or proportionate dimensions of the vegetative cell.
Decreased tolerance of the normal, usual, or expected events towards TMB-8.
increased sensitivity to 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester
OBSOLETE. Deviation from the normal, usual, or expected events during morphogenesis.
Deviation from the normal, usual, or expected morphology of the sorus.
Complete inability for division of prespore cells.
OBSOLETE. Complete inability for vacuolation.
Increase in relative or proportionate dimensions of the sorus.
Deviation from the normal, usual, or expected sorus color.
obsolete partial suppression of tagB mutation
Reduction in extent, amount, or degree of cell polarity establishment.
decreased establishment of cell polarity
Reduction in extent, amount, or degree of cell-substrate adhesion.
Reduction in extent, amount, or degree of cell proliferation.
decreased growth rate in bacterial suspension
decreased growth rate in liquid medium on solid surfaces
decreased growth rate in suspension at low temperature
decreased growth rate on bacterial plates
decreased growth rates on solid surfaces
merged_decreased growth rate at low cell density
merged_decreased growth rate in suspension in the presence of lithium
merged_decreased growth rate in the presence of gossypol
merged_decreased growth rate in the presence of ion chelators
OBSOLETE. Reduction in extent, amount or degree of activation of protein kinase B.
Not sure this is legitimate. See SF for an item on PKB; I think it's a gee product.
obsolete decreased activation of protein kinase B
Deviation from the normal, usual, or expected events during cytoskeleton organization.
obsolete no synthetic interaction observed between rasS and gefB
Reduction in extent, amount, or degree of endocytosis.
Increase in extent, amount, or degree of chemotaxis rate during the locomotory response to a chemical concentration gradient.
Increase in extent, amount, or degree of resistance to cisplatin.
OBSOLETE. Increase in extent, amount, or degree of intracellular cAMP level.
obsolete increased intracellular cAMP level
Increase in extent, amount, or degree of prestalk cell specific gene expression.
increased prestalk cell specific gene expression
Increase in extent, amount, or degree for prespore cell specific gene expression.
increased prespore gene cell specific expression
Increase in extent, amount, or degree of phagocytosis.
Increase in relative or proportionate dimensions of the vegetative cell.
OBSOLETE. Reduction in extent, amount or degree of chemoattractant-mediated F-actin polymerization.
obsolete decreased chemoattractant-mediated F-actin polymerization
Increase in extent, amount, or degree of tolerance to carboplatin.
Decreased tolerance of the normal, usual, or expected events towards carboplatin.
Decreased tolerance of the normal, usual, or expected events towards cisplatin.
Increased tolerance of the normal, usual, or expected events towards heat.
Deviation from the normal, usual, or expected events during cell-cell adhesion.
Deviation from the normal, usual, or expected events during organization of the microtubule cytoskeleton.
aberrant microtubule cytoskeleton organization
Decreased tolerance of the normal, usual, or expected events towards heat.
OBSOLETE. Prespore gene expression occurring in an abnormal position or in an unusual manner or form.
obsolete mislocalized prespore gene expression
OBSOLETE. Reduction in extent, amount or degree of cAMP-induced Ca2+ influx.
obsolete decreased cAMP-induced Ca2+ influx
OBSOLETE. Late onset or slower progression for cAMP-induced Ca2+ influx.
obsolete delayed cAMP-induced Ca2+ influx
OBSOLETE. Reduction in extent, amount or degree of Ca2+ induced Ca2+ influx.
obsolete decreased Ca2+-induced Ca2+ influx
obsolete decreased infection rate by Legionella pneumophila
Reduction in extent, amount, or degree of the resistance to hydrogen peroxide.
decreased resistance to hydrogen peroxide
Deviation from the normal, usual, or expected events during the response to UV light.
OBSOLETE Decreased tolerance of the normal, usual, or expected events towards mitomycin C (MMC).
obsolete decreased resistance to mitomycin C
Reduction in extent, amount or accumulation of fatty acid.
Deviation from the normal, usual, or expected process of vesicle coat assembly.
Reduction in extent, amount, or degree of pinocytosis.
The G1 phase in the mitotic cell cycle cannot complete.
Deviation from the normal, usual, or expected events during glycogen metabolism.
Increase in extent, amount, or degree of secretion of lysosomal enzymes.
increased secretion of lysosomal enzymes
Deviation from the normal, usual, or expected events during pinosome maturation.
Reduction in extent, amount, or degree of actin nucleation.
decreased actin nucleation on plasma membranes
Increase in extent, amount, or degree of resistance to 5-Fluoroorotic acid.
increased resistance to 5-Fluoroorotic acid
Complete inability to produce thymidine.
abolished thymidine biosynthetic process
obsolete increased extracellular of CF50 level
OBSOLETE. Increase in extent, amount, or degree of counting factr component level.
obsolete increased extracellular counting factor component(s) level
Reduction in extent, amount, or degree of secretion of lysosomal enzymes.
decreased secretion of lysosomal enzymes
OBSOLETE. Increase in extent, amount, or degree of intracellular counting factor (CF) level.
obsolete increased intracellular counting factor component(s) level
Increase in extent, amount, or degree of migration of slugs.
Deviation from the normal, usual, or expected mound color.
OBSOLETE. Increase in extent, amount, or degree of myosin protein level.
Increase in extent, amount, or degree of pinocytosis.
OBSOLETE. Quantitative increase in peripheral cells during sexual reproduction.
obsolete increased number of peripheral cells during sexual reproduction
Reduction in extent, amount, or degree of macrocysts size.
Complete inability to localize a protein to the nucleus.
abolished protein localization to nucleus
Reduction in extent, amount, or degree of cGMP biosynthesis.
Increase in extent, amount, or degree of cGMP biosynthesis.
OBSOLETE. Increase in amount or accumulation of actin phosphorylation.
obsolete increased actin phosphorylation
OBSOLETE. Deviation from the normal, usual, or expected events during actin phosphorylation.
Increase in extent, amount, or degree of F-actin polymerization.
decreased regulation of intracellular pH
Reduction in extent, amount, or degree of filopodium formation.
Early onset or faster progression of prespore cell specific gene expression.
precocious prespore cell specific gene expression
Deviation from the normal, usual, or expected during localization of a protein to contractile vacuole.
aberrant protein localization to contractile vacuole
OBSOLETE. Complete inability for cAMP-induced Ca2+ influx.
obsolete abolished cAMP-induced Ca2+ influx
Deviation from the normal, usual, or expected localization of a protein.
Use for the altered localization of a protein that is affected by the mutation of another gene product.
Deviation from the normal, usual, or expected events during the regulation of protein modification.
aberrant regulation of protein modification process
aberrant regulation of protein modification
Increase in extent, amount, or degree of cell polarity establishment.
increased establishment of cell polarity
Reduction in extent, amount, or degree of formation of lateral pseudopodia.
decreased lateral pseudopodium formation
Increase in extent, amount, or degree of resistance to the drug alendronic acid.
Deviation from the normal, usual, or expected events during lateral pseudopodium formation.
Increase in extent, amount, or degree of formation of lateral pseudopods.
increased lateral pseudopodium formation
OBSOLETE. Decreased tolerance of the normal, usual, or expected events in the presence of DNA damaging agents.
obsolete decreased resistance to DNA-damaging agents
OBSOLETE. Deviation from the normal, usual, or expected events during cAMP signaling.
OBSOLETE. Reduction in extent, amount, or degree of actin phosphorylation.
obsolete decreased actin phosphorylation
Deviation from the normal, usual, or expected process of streaming.
aberrant stream development during sorocarp development
Deviation from the normal, usual, or expected events during aggregation.
aberrant aggregation involved in sorocarp development
merged_aberrant formation of the aggregation territory
Increase in extent, amount, or degree of resistance to the antibiotic spectinomycin.
Complete inability for cells to migrate to the prestalk region during the slug stage.
abolished cell migration to prestalk region
Late onset or slower progression in the response to cAMP.
OBSOLETE. Increase in extent, amount, or degree of cytosolic Ca2+ response.
obsolete increased cytosolic Ca2+ response
Reduction in extent, amount, or degree of uptake of extracellular calcium.
Complete inability for a defence response to a bacterium.
Complete inability for streaming during early development.
abolished stream development during sorocarp development
OBSOLETE. Complete inability for CRAC localization to the plasma membrane.
obsolete abolished CRAC localization to the plasma membrane
OBSOLETE. Deviation from the normal, usual, or expected events during the adaptation of adenylate cyclase.
obsolete aberrant adaptation of adenylate cyclase
OBSOLETE. Reduction in extent, amount, or degree of cytosine methylation in genomic DNA.
obsolete decreased DNA methylation on cytosine
Complete inability to form autophagic vacuoles.
Complete inability for cell-substrate adhesion.
Early onset or faster progression through culmination.
precocious culmination involved in sorocarp development
Reduction in extent, amount, or degree of spore formation.
OBSOLETE. Late onset or slower progression for development in the oresence of TMB-8.
obsolete delayed development in the presence of TMB-8
Deviation from the normal, usual, or expected events during stalk morphogenesis.
Complete inability for differentiation of prestalk cells.
Deviation from the normal, usual, or expected events during spore formation.
Complete inability for differentiation into stalk cells.
Complete inability for differentiation of prespore cells.
Complete inability to localize a protein to the contractile vacuole.
abolished protein localization to contractile vacuole
Deviation from the normal, usual, or expected during localization of a protein to the contractile vacuole membrane.
aberrant protein localization to contractile vacuolar membrane
aberrant protein localization to contractile vacuole membrane
OBSOLETE. Complete inability for differentiation into stalk cells in vitro.
obsolete abolished stalk cell differentiation in vitro
Complete inability to localize a protein to the contractile vacuole membrane.
abolished localization to contractile vacuolar membrane
abolished protein localization to contractile vacuole membrane
Reduction in extent, amount, or degree of chemotaxis in response to cAMP.
Reduction in extent, amount, or degree of chemotaxis in response to folate.
decreased positive chemotaxis to folic acid
Increase in extent, amount, or degree of cell migration to the prestalk region during the slug stage.
increased cell migration to prestalk region
Increase in relative or proportionate duration of the mitotic cell cycle.
OBSOLETE Increase in extent, amount, or degree of prestalk differentiation factor.
obsolete increased prestalk cell differentiation in response to DIF-1
OBSOLETE Complete inability for methylation of histone H3 at lysine 4.
obsolete abolished histone H3-K4 methylation
Increase in extent, amount, or degree of endocytosis.
Increase in extent, amount, or degree of differentiation into stalk cells.
Increase in extent, amount, or degree of co-transciptional gene silencing by RNA.
increased small RNA-mediated cotranscriptional gene silencing
increased co-transcriptional gene silencing by RNA interference machinery
Increase in relative or proportionate dimensions of the contractile vacuole.
Quantitative increase in contractile vacuoles.
increased number of contractile vacuoles
Deviation from the normal, usual, or expected events during mitotic anaphase.
Reduction in amount or accumulation of intracellular glycogen.
Increase in amount or accumulation of intracellular glutamate.
Increase in amount or accumulation of ammonia.
Reduction in amount or accumulation of intracellular pteridine.
Increase in relative or proportionate dimensions of the pseudopodium.
obsolete increased infection rate by Legionella pneumophila
increased sensitivity to infection by Mycobacterium avium
obsolete increased infection rate by Mycobacterium avium
Increase in extent, amount, or degree of transport of iron.
Deviation from the normal, usual, or expected events during differentiation of stalk cells.
Deviation from the normal, usual, or expected morphogenesis of the late culminant.
Complete inability to perform phagocytosis.
Increase in extent, amount, or degree of formation of pseudopodia.
Complete inability to form a functional contractile vacuole.
abolished contractile vacuole organization
Deviation from the normal, usual, or expected contractile vacuole localization.
aberrant contractile vacuole localization
Deviation from the normal, usual, or expected events during contractile vacuole attachment to the plasma membrane involved in discharge.
aberrant contractile vacuole tethering to plasma membrane
aberrant contractile vacuole tethering involved in discharge
Complete inability for contractile vacuole tethering involved in discharge.
abolished contractile vacuole tethering to plasma membrane
abolished contractile vacuole tethering involved in discharge
Deviation from the normal, usual, or expected events during contractile vacuole dissociation from plasma membrane after discharge.
aberrant contractile vacuole detethering from plasma membrane
aberrant contractile vacuole dissociation from plasma membrane
Complete inability of contractile vacuole dissociation from plasma membrane after discharge.
abolished contractile vacuole detethering from plasma membrane
abolished contractile vacuole dissociation from plasma membrane
Deviation from the normal, usual, or expected events during pore formation, part of contractile vacuole discharge.
aberrant pore formation during contractile vacuole discharge
Complete inability for pore formation, part of contractile vacuole discharge.
abolished pore formation during contractile vacuole discharge
Deviation from the normal, usual, or expected events during homotypic fusion of endocytic vesicles to form or add to an early endosome.
Reduction in extent, amount, or degree of homotypic fusion of endocytic vesicles to form or add to an early endosome.
Increase in extent, amount, or degree of homotypic fusion of endocytic vesicles to form or add to an early endosome.
Deviation from the normal, usual, or expected events during endoplasmic reticulum organization.
aberrant endoplasmic reticulum organization
Deviation from the normal, usual, or expected events during endoplasmic reticulum membrane organization.
aberrant endoplasmic reticulum membrane organization
OBSOLETE. Quantitative increase in endoplasmic reticulum membrane accumulation.
obsolete increased endoplasmic reticulum membrane accumulation
Deviation from the normal, usual, or expected storage of lipids.
Deviation from the normal, usual, or expected formation of lipid droplets.
Reduction in amount or accumulation of lipid droplets.
Increase in amount or accumulation of lipid droplets.
Complete inability to form lipid droplets.
Deviation from the normal, usual, or expected events during double-strand break repair of DNA via homologous recombination.
aberrant DSB repair via homologous recombination
aberrant double-strand break repair via HR
aberrant double-strand break repair via homologous recombination
Reduction in extent, amount, or degree of double strand break repair of DNA via homologous recombination.
decreased DSB repair via homologous recombination
decreased double-strand break repair via HR
decreased double-strand break repair via homologous recombination
Complete inability for double strand break repair of DNA via homologous recombination.
abolished DSB repair via homologous recombination
abolished double-strand break repair via HR
abolished double-strand break repair via homologous recombination
Increased tolerance of the normal, usual, or expected events in double-strand break repair of DNA via homologous recombination.
increased DSB repair via homologous recombination
increased double-strand break repair via HR
increased double-strand break repair via homologous recombination
Deviation from the normal, usual, or expected events during double-strand break repair of DNA via nonhomologous end joining.
aberrant DSB repair via nonhomologous end joining
aberrant double-strand break repair via NHEJ
aberrant double-strand break repair via nonhomologous end joining
Complete inability for double strand break repair of DNA via nonhomologous end joining.
abolished DSB repair via nonhomologous end joining
abolished double-strand break repair via NHEJ
abolished double-strand break repair via nonhomologous end joining
Reduction in extent, amount, or degree of double strand break repair of DNA via nonhomologous end joining.
decreased DSB repair via nonhomologous end joining
decreased double-strand break repair via NHEJ
decreased double-strand break repair via nonhomologous end joining
Increased tolerance of the normal, usual, or expected events in double-strand break repair of DNA nonhomologous end joining.
increased DSB repair via nonhomologous end joining
increased double-strand break repair via NHEJ
increased double-strand break repair via nonhomologous end joining
Deviation from the normal, usual, or expected sorting to prestalk region when mixed with cheater cells.
aberrant cheating during chimeric sorocarp development
Increase in extent, amount, or degree of resistance towards cheater cells compared to wild type.
increased resistance to cheating during chimeric sorocarp development
increased resistance to cheating during development
Decreased tolerance of the normal, usual, or expected events towards cheater cells compared to wild type.
decreased resistance to cheating during chimeric sorocarp development
decreased resistance to cheating during development
OBSOLETE. Complete resistance to cheating when mixed with cheater cells.
Deviation from the normal, usual, or expected events when determining the mating type of a cell.
Complete inability for determining the mating type of a cell.
Deviation from the normal, usual, or expected events during the cellular response to lowered oxygen tension.
aberrant cellular response to decreased oxygen
Decreased cellular response to the normal, usual, or expected events in the presence of lower oxygen levels.
decreased cellular response to lowered oxygen levels
decreased response to cellular hypoxic stress
Increased cellular response to the normal, usual, or expected events in the presence of lower oxygen levels.
increased cellular response to hypoxic stress
increased cellular response to lowered oxygen levels
Reduction in extent, amount, or degree of the response to Gram-positive bacterium as a food source.
decreased growth on Gram-positive bacteria
Gram-positive bacteria (examples): B. subtilis S. aureus M. luteus.
decreased response to Gram-positive bacterium
Complete inability for cells to respond to Gram-positive bacteria as a food source.
abolished growth on Gram-positive bacteria
abolished response to Gram-positive bacterium
Reduction in extent, amount, or degree of the response to Gram-negative bacterium as a food source.
decreased growth on Gram-negative bacteria
Gram-negative bacteria (examples): K. pneumonia E. coli P. aeruginosa.
decreased response to Gram-negative bacterium
Complete inability for a response to Gram-negative bacteria as a food source.
abolished growth on Gram-negative bacteria
abolished response to Gram-negative bacterium
Deviation from the normal, usual, or expected events during the response to bacteria.
Complete inability for a response to bacteria as a food source.
Reduction in extent, amount, or degree of the response to bacteria as a food source.
OBSOLETE. Increase in extent, amount, or degree of typically cortical actin wave formation.
Reduction of the time span a spore is viable after sporulation.
Early onset or faster progression through contractile vacuole discharge.
precocious contractile vacuole discharge
Quantitative reduction of the post-lysosomal vacuole number.
decreased number of post-lysosomal vacuoles
Decrease in relative or proportionate dimensions of the post-lysosomal vacuole.
Deviation from the normal, usual, or expected events during organization of intermediate filaments.
aberrant intermediate filament organization
Deviation from the normal, usual, or expected events during intermediate filament bundle assembly.
aberrant intermediate filament bundle assembly
Quantitative increase in intermediate filament bundle assembly.
increased intermediate filament bundle assembly
Reduction in extent, amount, or degree of intermediate filament bundle assembly.
decreased intermediate filament bundle assembly
Deviation from the normal, usual, or expected events during localization of a protein to the leading edge.
aberrant protein localization to cell leading edge
aberrant protein localization to leading edge
Complete inability to localize a protein to the leading edge.
abolished protein localization to cell leading edge
abolished protein localization to leading edge
Reduction in amount or accumulation of a protein to the leading edge.
decreased protein localization to cell leading edge
decreased protein localization to leading edge
Increase in amount or accumulation of a protein to the leading edge.
increased protein localization to cell leading edge
increased protein localization to leading edge
Deviation from the normal, usual, or expected events during localization of a protein to the actin wave.
aberrant protein localization to actin wave
Complete inability to localize a protein to the actin wave.
abolished protein localization to actin wave
Reduction in amount or accumulation of a protein to the actin wave.
decreased protein localization to actin wave
Increase in amount or accumulation of a protein to the actin wave.
increased protein localization to actin wave
Deviation from the normal, usual, or expected events during localization of a protein to the trailing edge.
aberrant protein localization to cell trailing edge
aberrant protein localization to trailing edge
Complete inability to localize a protein to the trailing edge.
abolished protein localization to cell trailing edge
abolished protein localization to trailing edge
Reduction in amount or accumulation of a protein to the trailing edge.
decreased protein localization to cell trailing edge
decreased protein localization to trailing edge
Increase in amount or accumulation of a protein to the trailing edge.
increased protein localization to cell trailing edge
increased protein localization to trailing edge
Deviation from the normal, usual, or expected events during localization of a protein to the filopodia.
aberrant protein localization to filopodium
Complete inability to localize a protein to the filopodia.
abolished protein localization to filopodium
Reduction in amount or accumulation of a protein to the filopodia.
decreased protein localization to filopodium
Increase in amount or accumulation of a protein to the filopodia.
increased protein localization to filopodium
Deviation from the normal, usual, or expected events during localization of a protein to the phagocytic vesicle.
aberrant protein localization to phagosome
aberrant protein localization to phagocytic vesicle
Complete inability to localize a protein to the phagocytic vesicle.
abolished protein localization to phagosome
abolished protein localization to phagocytic vesicle
Reduction in amount or accumulation of a protein to the phagocytic vesicle.
decreased protein localization to phagosome
decreased protein localization to phagocytic vesicle
Increase in amount or accumulation of a protein to the phagocytic vesicle.
increased protein localization to phagosome
increased protein localization to phagocytic vesicle
Deviation from the normal, usual, or expected events during localization of a protein to the centrosome.
aberrant protein localization to centrosome
Complete inability to localize a protein to the centrosome.
abolished protein localization to centrosome
Reduction in amount or accumulation of a protein to the centrosome.
decreased protein localization to centrosome
Increase in amount or accumulation of a protein to the centrosome.
increased protein localization to centrosome
Deviation from the normal, usual, or expected events during localization of a protein to the macropinosome.
aberrant protein localization to macropinocytic cup
aberrant protein localization to macropinosome
Complete inability to localize a protein to the macropinosome.
abolished protein localization to macropinocytic cup
abolished protein localization to macropinosome
Reduction in amount or accumulation of a protein to the macropinosome.
decreased protein localization to macropinocytic cup
decreased protein localization to macropinosome
Increase in amount or accumulation of a protein to the macropinosome.
increased protein localization to macropinocytic cup
increased protein localization to macropinosome
Deviation from the normal, usual, or expected events during localization of a protein to the autophagosome.
aberrant protein localization to autophagosome
Complete inability to localize a protein to the autophagosome.
abolished protein localization to autophagosome
Reduction in amount or accumulation of a protein to the autophagosome.
decreased protein localization to autophagosome
Increase in amount or accumulation of a protein to the autophagosome.
increased protein localization to autophagosome
Deviation from the normal, usual, or expected events during localization of a protein to the cell-cell contact zone.
aberrant protein localization to cell-cell contact zone
Complete inability to localize a protein to the cell-cell contact zone.
abolished protein localization to cell-cell contact zone
Reduction in amount or accumulation of a protein to the cell-cell contact zone.
decreased protein localization to cell-cell contact zone
Increase in amount or accumulation of a protein to the cell-cell contact zone.
increased protein localization to cell-cell contact zone
Deviation from the normal, usual, or expected events during localization of a protein to the basolateral plasma membrane.
aberrant protein localization to basolateral plasma membrane
Complete inability to localize a protein to the basolateral plasma membrane.
abolished protein localization to basolateral plasma membrane
Reduction in amount or accumulation of a protein to the basolateral plasma membrane.
decreased protein localization to basolateral plasma membrane
Increase in amount or accumulation of a protein to the basolateral plasma membrane.
increased protein localization to basolateral plasma membrane
Deviation from the normal, usual, or expected events during localization of a protein to the cleavage furrow.
aberrant protein localization to cleavage furrow
Complete inability to localize a protein to the cleavage furrow.
abolished protein localization to cleavage furrow
Reduction in amount or accumulation of a protein to the cleavage furrow.
decreased protein localization to cleavage furrow
Increase in amount or accumulation of a protein to the cleavage furrow.
increased protein localization to cleavage furrow
Deviation from the normal, usual, or expected events during localization of a protein to the lysosome.
aberrant protein localization to lysosome
Complete inability to localize a protein to the lysosome.
abolished protein localization to lysosome
Reduction in amount or accumulation of a protein to the lysosome.
decreased protein localization to lysosome
Increase in amount or accumulation of a protein to the lysosome.
increased protein localization to lysosome
Deviation from the normal, usual, or expected events during localization of a protein to the post-lysosomal vacuole.
aberrant protein localization to postlysosome
aberrant protein localization to post-lysosomal vacuole
Complete inability to localize a protein to the post-lysosomal vacuole.
abolished protein localization to postlysosome
abolished protein localization to post-lysosomal vacuole
Reduction in amount or accumulation of a protein to the post-lysosomal vacuole.
decreased protein localization to postlysosome
decreased protein localization to post-lysosomal vacuole
Increase in amount or accumulation of a protein to the post-lysosomal vacuole.
increased protein localization to postlysosome
increased protein localization to post-lysosomal vacuole
Deviation from the normal, usual, or expected events during localization of a protein to the lysosomal membrane.
aberrant protein localization to lysosome membrane
aberrant protein localization to lysosomal membrane
Complete inability to localize a protein to the lysosomal membrane.
abolished protein localization to lysosome membrane
abolished protein localization to lysosomal membrane
Reduction in amount or accumulation of a protein to the lysosomal membrane.
decreased protein localization to lysosome membrane
decreased protein localization to lysosomal membrane
Increase in amount or accumulation of a protein to the lysosomal membrane.
increased protein localization to lysosome membrane
increased protein localization to lysosomal membrane
Deviation from the normal, usual, or expected events during localization of a protein to the mitotic spindle.
aberrant protein localization to mitotic spindle
Complete inability to localize a protein to the mitotic spindle.
abolished protein localization to mitotic spindle
Reduction in amount or accumulation of a protein to the mitotic spindle.
decreased protein localization to mitotic spindle
Increase in amount or accumulation of a protein to the mitotic spindle.
increased protein localization to mitotic spindle
Deviation from the normal, usual, or expected events during localization of a protein to the mitotic spindle midzone.
aberrant protein localization to mitotic spindle midzone
Complete inability to localize a protein to the mitotic spindle midzone.
abolished protein localization to mitotic spindle midzone
Reduction in amount or accumulation of a protein to the mitotic spindle midzone.
decreased protein localization to mitotic spindle midzone
Increase in amount or accumulation of a protein to the mitotic spindle midzone.
increased protein localization to mitotic spindle midzone
Deviation from the normal, usual, or expected events during localization of a protein to the cytoplasmic vesicle.
aberrant protein localization to cytoplasmic vesicle
Complete inability to localize a protein to the cytoplasmic vesicle.
abolished protein localization to cytoplasmic vesicle
Reduction in amount or accumulation of a protein to the cytoplasmic vesicle.
decreased protein localization to cytoplasmic vesicle
Increase in amount or accumulation of a protein to the cytoplasmic vesicle.
increased protein localization to cytoplasmic vesicle
Deviation from the normal, usual, or expected events during localization of a protein to the cell periphery.
aberrant protein localization to cell periphery
Complete inability to localize a protein to the cell periphery.
abolished protein localization to cell periphery
Deviation from the normal, usual, or expected events during localization of a protein from the cytoplasm to the apical plasma membrane.
aberrant protein localization to apical plasma membrane
Complete inability to localize a protein to the apical plasma membrane.
abolished protein localization to apical plasma membrane
Deviation from the normal, usual, or expected events during localization of a protein to the endolysosome.
aberrant protein localization to endolysosome
Complete inability to localize a protein to the endolysosome.
abolished protein localization to endolysosome
Reduction in amount or accumulation of a protein to the endolysosome.
decreased protein localization to endolysosome
Increase in amount or accumulation of a protein to the endolysosome.
increased protein localization to endolysosome
Reduction in amount or accumulation of a protein to the contractile vacuole.
decreased protein localization to contractile vacuole
Increase in amount or accumulation of a protein to the contractile vacuole.
increased protein localization to contractile vacuole
Reduction in amount or accumulation of a protein to the contractile vacuole membrane.
decreased protein localization to contractile vacuole membrane
Increase in amount or accumulation of a protein to the contractile vacuole membrane.
increased protein localization to contractile vacuole membrane
Complete inability to form a functional vacuole.
Development cannot progress past the standing slug stage.
development arrests at standing slug stage
Development cannot progress past the early culminant stage.
development arrests at mexican hat stage
development arrests at early culminant stage
Development cannot progress past the mid culminant stage.
development arrests at mid culminant stage
Development cannot progress past the late culminant stage.
development arrests at late culminant stage
Deviation from the normal, usual, or expected events during G protein-coupled signaling.
aberrant G protein-coupled receptor signaling pathway
aberrant G protein-coupled receptor signaling
Deviation from the normal, usual, or expected events during differentiation into spores during culmination.
aberrant sorocarp spore cell differentiation
Complete inability for differentiation of spore cells during culmination.
abolished sorocarp spore cell differentiation
Reduction in extent, amount, or degree of differentiation into spore cells during culmination.
decreased sorocarp spore cell differentiation
Complete inability for response to a biotic stimulus.
Deviation from the normal, usual, or expected events during cGMP-mediated signaling.
Deviation from the normal, usual, or expected cAMP level.
Reduction in extent, amount, or degree of the cAMP level.
Increase in extent, amount, or degree of cAMP level.
Deviation from the normal, usual, or expected events during epithelium-like organization.
Reduction in extent, amount, or degree of epithelium-like organization.
Complete inability for epithelium-like organization.
Deviation from the normal, usual, or expected events during the development of the aggregation territory size.
Reduction in relative or proportionate dimensions of the aggregation territory.
Increase in relative or proportionate dimensions of the aggregation territory.
Complete inability for cAMP biosynthesis.
Reduction in extent, amount, or degree of uptake of cAMP biosynthesis.
Increase in extent, amount, or degree of cAMP biosynthesis.
OBSOLETE. Deviation from the normal, usual, or expected during the response to phleomycin.
obsolete aberrant response to phleomycin
Decreased tolerance of the normal, usual, or expected events in the presence of phleomycin.
Increased tolerance of the normal, usual, or expected events in the presence of phleomycin.
Deviation from the normal, usual, or expected during the response to bleomycin.
Decreased tolerance of the normal, usual, or expected events in the presence of bleomycin.
Increased tolerance of the normal, usual, or expected events in the presence of bleomycin.
Deviation from the normal, usual, or expected events during the response to hydroxyurea.
Increase in extent, amount, or degree of resistance to hydroxyurea.
Decreased tolerance of the normal, usual, or expected events towards hydroxyurea.
Reduction in level of modification of siRNA production involved in RNA interference.
decreased production of siRNA involved in RNAi
decreased regulation of siRNA processing
The M phase in the mitotic cell cycle cannot complete.
Increase in relative or proportionate dimensions of the post-lysosomal vacuole.
OBSOLETE. Complete inability to phosphorylate a tyrosine residue of a protein.
obsolete abolished protein tyrosin phosphorylation
Increase in extent, amount, or degree of suppression or retraction of lateral pseudopods.
increased lateral pseudopodium retraction
Complete inability for prestalk cell specific gene expression.
abolished prestalk cell specific gene expression
Complete inability for prespore cell specific gene expression.
abolished prespore cell specific gene expression
Deviation from the normal, usual, or expected events during protein kinase activity.
Complete absence of protein tyrosine kinase activity.
abolished protein tyrosine kinase activity
Reduction in extent, amount, or degree of protein tyrosine kinase activity.
decreased protein tyrosine kinase activity
Increase in extent, amount, or degree of protein tyrosine kinase activity.
increased protein tyrosine kinase activity
Deviation from the normal, usual, or expected events during protein tyrosine kinase activity.
aberrant protein tyrosine kinase activity
Deviation from the normal, usual, or expected activity of a transferase.
Deviation from the normal, usual, or expected activity of histone H3K4 methyltransferase activity.
aberrant histone H3K4 methyltransferase activity
Complete absence of histone H3K4 methyltransferase activity.
abolished histone H3K4 methyltransferase activity
Deviation from the normal, usual, or expected activity of histone H3K79 methyltransferase activity.
aberrant histone H3K79 methyltransferase activity
Complete absence of histone H3K79 methyltransferase activity.
abolished histone H3K79 methyltransferase activity
Deviation from the normal, usual, or expected activity of histone H3K9 methyltransferase activity.
aberrant histone H3K9 methyltransferase activity
Complete absence of histone H3K9 methyltransferase activity.
abolished histone H3K9 methyltransferase activity
Deviation from the normal, usual, or expected events during myosin heavy chain kinase activity.
aberrant myosin heavy chain kinase activity
Complete absence of myosin heavy chain kinase activity.
abolished myosin heavy chain kinase activity
Deviation from the normal, usual, or expected activity of DNA methyltransferase activity.
Reduction in extent, amount, or degree of DNA methyltransferase activity.
decreased DNA methyltransferase activity
decreased DNA-methyltransferase activity
Deviation from the normal, usual, or expected events during the regulation of MAPK cascade.
Complete inability to regulate the MAPK cascade.
Deviation from the normal, usual, or expected events during protein kinase B signaling.
Reduction in extent, amount, or degree of activation of protein kinase B signaling.
Increase in extent, amount, or degree of protein kinase B signaling.
Complete absence of protein kinase B signaling.
Deviation from the normal, usual, or expected activity of prenylcysteine carboxyl methyltransferase activity.
aberrant protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity
aberrant prenylcysteine carboxyl methyltransferase activity
Complete absence of prenylcysteine carboxyl methyltransferase activity.
abolished protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity
abolished prenylcysteine carboxyl methyltransferase activity
Deviation from the normal, usual, or expected events during the cellular DNA damage response.
aberrant cellular response to DNA damage stimulus
Deviation from the normal, usual, or expected events during phosphatase activity.
Reduction in extent, amount, or degree of phosphatase activity.
Increase in extent, amount, or degree of phosphatase activity.
Complete absence of phosphatase activity.
Deviation from the normal, usual, or expected events during protein tyrosine phosphatase activity.
aberrant protein tyrosine phosphatase activity
Reduction in extent, amount, or degree of protein tyrosine phosphatase activity.
decreased protein tyrosine phosphatase activity
Increase in extent, amount, or degree of protein tyrosine phosphatase activity.
increased protein tyrosine phosphatase activity
Complete absence of protein tyrosine phosphatase activity.
abolished protein tyrosine phosphatase activity
Deviation from the normal, usual, or expected events during the STAT signaling pathway.
aberrant receptor signaling pathway via STAT
Complete absence of the STAT signaling pathway.
abolished receptor signaling pathway via STAT
Deviation from the normal, usual, or expected events during the regulation of the STAT signaling pathway.
aberrant regulation of receptor signaling pathway via STAT
aberrant regulation of STAT signaling pathway
Reduction in extent, amount, or degree of the regulation of STAT signaling pathway.
decreased regulation of receptor signaling pathway via STAT
decreased regulation of STAT signaling pathway
Complete absence of the regulation of STAT signalling pathway.
abolished regulation of receptor signaling pathway via STAT
abolished regulation of STAT signaling pathway
Deviation from the normal, usual, or expected events during Ras protein signal transduction.
aberrant Ras protein signal transduction
Reduction in extent, amount, or degree of activation of Ras protein signal transduction.
decreased Ras protein signal transduction
Increase in extent, amount, or degree of Ras protein signal transduction.
increased Ras protein signal transduction
Complete absence of Ras protein signal transduction.
abolished Ras protein signal transduction
Deviation from the normal, usual, or expected events during protein-containing complex assembly.
aberrant cellular protein complex assembly
aberrant protein-containing complex assembly
Reduction in extent, amount, or degree of cell-cell self recognition.
Decreased tolerance of the normal, usual, or expected event during cellular DNA damage response.
decreased cellular response to DNA damage stimulus
Increased tolerance of the normal, usual, or expected events during cellular DNA damage response.
increased cellular response to DNA damage stimulus
Complete inability to respond to DNA damage.
abolished cellular response to DNA damage stimulus
Deviation from the normal, usual, or expected events during programmed cell death.
Increase in extent, amount, or degree of programmed cell death.
Reduction in extent, amount, or degree of programmed cell death.
Deviation from the normal, usual, or expected activity of a signaling receptor.
Deviation from the normal, usual, or expected activity of a G-protein coupled chemorepellent receptor activity.
aberrant G protein-coupled chemorepellent receptor activity
aberrant G protein-coupled chemorepellent receptor signaling pathway
Reduction in extent, amount, or degree of G-protein coupled chemorepellent receptor activity.
decreased G protein-coupled chemorepellent receptor activity
decreased G protein-coupled chemorepellent receptor signaling pathway
Increased in extent, amount, or degree of G-protein coupled chemorepellent receptor activity.
increased G protein-coupled chemorepellent receptor activity
increased G protein-coupled chemorepellent receptor signaling pathway
Complete absence of G-protein coupled chemorepellent receptor activity.
abolished G protein-coupled chemorepellent receptor activity
abolished G protein-coupled chemorepellent receptor signaling pathway
Reduction in extent, amount, or degree of protein localization to mitotic actomyosin contractile ring.
decreased protein localization to mitotic actomyosin contractile ring
Increase in extent, amount, or degree of heterotrimeric G-protein complex assembly.
increased heterotrimeric G-protein complex assembly
Deviation from the normal, usual, or expected activity of DNA cytosine-5-)-methyltransferase activity.
aberrant DNA 5-cytosine methylase activity
aberrant DNA (cytosine-5-)-methyltransferase activity
Reduction in extent, amount, or degree of DNA (cytosine-5-)-methyltransferase activity.
decreased DNA 5-cytosine methylase activity
decreased DNA (cytosine-5-)-methyltransferase activity
Complete absence of DNA (cytosine-5-)-methyltransferase activity.
abolished DNA 5-cytosine methylase activity
abolished DNA (cytosine-5-)-methyltransferase activity
Deviation from the normal, usual, or expected molecular function regulator activity.
aberrant molecular function regulator activity
Deviation from the normal, usual, or expected adenylate cyclase regulator activity.
aberrant adenylate cyclase regulator activity
A reduction in extent, amount, or degree of adenylate cyclase regulator activity.
decreased adenylate cyclase regulator activity
Complete absence of adenylate cyclase regulator activity.
abolished adenylate cyclase regulator activity
Deviation from the normal, usual, or expected adenylate cyclase activator activity.
aberrant adenylate cyclase activator activity
Reduction in extent, amount, or degree of adenylate cyclase activator activity.
decreased adenylate cyclase activator activity
Complete absence of adenylate cyclase activator activity.
abolished adenylate cyclase activator activity
Deviation from the normal, usual, or expected protein kinase regulator activity.
aberrant protein kinase regulator activity
Increase in extent, amount, or degree of protein kinase regulator activity.
increased protein kinase regulator activity
Reduction in extent, amount, or degree of protein kinase regulator activity.
decreased protein kinase regulator activity
Complete absence of protein kinase regulator activity.
abolished protein kinase regulator activity
Deviation from the normal, usual, or expected protein localization to mitotic actomyosin contractile ring.
aberrant protein localization to mitotic actomyosin contractile ring
Complete inability for protein localization to mitotic actomyosin contractile ring.
abolished protein localization to mitotic actomyosin contractile ring
Deviation from the normal, usual, or expected GTPase regulator activity.
Deviation from the normal, usual, or expected GTPase activator activity.
Increase in extent, amount, or degree of GTPase activator activity.
Reduction in extent, amount, or degree of GTPase activator activity.
Complete absence of GTPase activator activity.
Deviation from the normal, usual, or expected events during autophagosome maturation.
Reduction in extent, amount, or degree of autophagosome maturation.
Complete absence of autophagosome maturation.
Deviation from the normal, usual, or expected events during heterotrimeric G-protein complex assembly.
aberrant heterotrimeric G-protein complex assembly
Reduction in extent, amount, or degree of heterotrimeric G-protein complex assembly.
decreased heterotrimeric G-protein complex assembly
Complete absence of heterotrimeric G-protein complex assembly.
abolished heterotrimeric G-protein complex assembly
Deviation from the normal, usual, or expected events during protein metabolic process.
Deviation from the normal, usual, or expected events during proteasomal protein catabolic process.
aberrant proteasomal protein catabolic process
Reduction in extent, amount, or degree of proteasomal protein catabolic process.
decreased proteasomal protein catabolic process
Complete absence of proteasomal protein catabolic process.
abolished proteasomal protein catabolic process
Deviation from the normal, usual, or expected events during ubiquitin-dependent protein catabolic process.
aberrant ubiquitin-dependent protein catabolic process
Reduction in extent, amount, or degree of ubiquitin-dependent protein catabolic process.
decreased ubiquitin-dependent protein catabolic process
Complete absence of ubiquitin-dependent protein catabolic process.
abolished ubiquitin-dependent protein catabolic process
Complete absence of programmed cell death.
Reduction in extent, amount, or degree of regulation of MAPK cascade.
Increase in extent, amount, or degree of regulation of MAPK cascade.
Deviation from the normal, usual, or expected events during TORC2 signaling.
Reduction in extent, amount, or degree of TORC2 signaling.
Increase in extent, amount, or degree of TORC2 signaling.
Deviation from the normal, usual, or expected events during Rab protein signal transduction.
aberrant Rab protein signal transduction
Reduction in extent, amount, or degree of activation of Rab protein signal transduction.
decreased Rab protein signal transduction
Increase in extent, amount, or degree of Rab protein signal transduction.
increased Rab protein signal transduction
Complete absence of Rab protein signal transduction.
abolished Rab protein signal transduction
Deviation from the normal, usual, or expected events during Rap protein signal transduction.
aberrant Rap protein signal transduction
Reduction in extent, amount, or degree of activation of Rap protein signal transduction.
decreased Rap protein signal transduction
Increase in extent, amount, or degree of Rap protein signal transduction.
increased Rap protein signal transduction
Complete absence of Rap protein signal transduction.
abolished Rap protein signal transduction
Deviation from the normal, usual, or expected events during Rac protein signal transduction.
aberrant Rac protein signal transduction
Reduction in extent, amount, or degree of activation of Rac protein signal transduction.
decreased Rac protein signal transduction
Increase in extent, amount, or degree of Rac protein signal transduction.
increased Rac protein signal transduction
Complete absence of Rac protein signal transduction.
abolished Rac protein signal transduction
Deviation from the normal, usual, or expected events during small GTPase mediated signal transduction.
aberrant small GTPase mediated signal transduction
Reduction in extent, amount, or degree of small GTPase mediated signal transduction.
decreased small GTPase mediated signal transduction
Increase in extent, amount, or degree of small GTPase mediated signal transduction.
increased small GTPase mediated signal transduction
Complete absence of small GTPase mediated signal transduction.
abolished small GTPase mediated signal transduction
OBSOLETE. Deviation from the normal, usual, or expected events duringninitiation of development.
obsolete aberrant initiation of development
Deviation from the normal, usual, or expected morphology of organelles.
Child of GO:0006996 : organelle organization and biogenesis.
Deviation from the normal, usual, or expected events during the response to stimulus.
Child of GO:0050896 : response to stimulus.
OBSOLETE. Deviation from the normal, usual, or expected events during cellular physiological process.
Obsoleted because GO merged with cellular process. All children moved under DDPHENO:0001008 aberrant cellular process
obsolete aberrant cellular physiological process
Deviation from the normal, usual, or expected events during cellular metabolism.
Child of GO:0044237: cellular metabolism.
Deviation from the normal, usual, or expected events during phagocytosis.
Deviation from the normal, usual, or expected events during pinocytosis.
Deviation from the normal, usual, or expected events during cellular processes.
Deviation from the normal, usual, or expected events during localization.
Deviation from the normal, usual, or expected events during sexual macrocyst formation.
aberrant aggregation during macrocyst formation
Child of GO:0000747: conjugation with cellular fusion.
OBSOLETE. Reduction in extent, amount or degree of intracellular cAMP level.
obsolete decreased intracellular cAMP level
Deviation from the normal, usual, or expected events during stalk development.
Deviation from the normal, usual, or expected events during cell differentiation.
Deviation from the normal, usual, or expected events during slug development.
aberrant slug development involved in sorocarp development
Deviation from the normal, usual, or expected events during culmination.
aberrant culmination involved in sorocarp development
Deviation from the normal, usual, or expected events during the regulation of fruiting body formation.
aberrant regulation of sorocarp development
aberrant regulation of fruiting body formation
Deviation from the normal, usual, or expected events during the development of mound size.
aberrant regulation of aggregation during fruiting body formation
Deviation from the normal, usual, or expected events during the regulation of stalk cell differentiation.
aberrant regulation of sorocarp stalk cell differentiation
aberrant regulation of stalk cell differentiation
Deviation from the normal, usual, or expected events during negative regulation of stalk cell differentiation.
aberrant negative regulation of sorocarp stalk cell differentiation
aberrant negative regulation of stalk cell differentiation
Deviation from the normal, usual, or expected events during positive regulation of stalk cell differentiation.
aberrant positive regulation of sorocarp stalk cell differentiation
aberrant positive regulation of stalk cell differentiation
Deviation from the normal, usual, or expected events during differentiation of prestalk cells.
Deviation from the normal, usual, or expected events during differentiation of prestalk O cells.
aberrant prestalk O cell differentiation
Deviation from the normal, usual, or expected events during differentiation of prespore cells.
Deviation from the normal, usual, or expected events during ion transport.
Deviation from the normal, usual, or expected events during pseudopodium formation.
Deviation from the normal, usual, or expected events during filopodium formation.
Deviation from the normal, usual, or expected events during establishment and/or maintenance of cell polarity.
aberrant establishment or maintenance of cell polarity
Deviation from the normal, usual, or expected events during protein secretion.
Deviation from the normal, usual, or expected events during the response to abiotic stimulus.
Deviation from the normal, usual, or expected events during the response to biotic stimulus.
Deviation from the normal, usual, or expected morphology of the macrocyst.
Deviation from the normal, usual, or expected events during the cellular response to stress.
Deviation from the normal, usual, or expected events during the response to heat.
aberrant cellular response to heat shock
Deviation from the normal, usual, or expected events during the response to oxidative stress.
OBSOLETE. Deviation from the normal, usual, or expected events during signal trnduction during aggregation.
obsolete aberrant signal transduction during aggregation
Deviation from the normal, usual, or expected events during extracellular cAMP signaling.
aberrant adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway
merged_aggregation hypersensitive to caffeine
merged_aggregation resistant to caffeine
merged_impaired cAMP signaling in the presence of gossypol
aberrant cAMP signaling during aggregation
Merged with aberrant cAMP signaling during aggregation. PG 10-24-2006.
aberrant extracellular cAMP signaling pathway
Deviation from the normal, usual, or expected events during the cellular response to starvation.
aberrant cellular response to starvation
OBSOLETE. Deviation from the normal, usual, or expected events during response to drug.
Deviation from the normal, usual, or expected process of vacuole organization.
Deviation from the normal, usual, or expected events during cellular component organization.
aberrant cellular component organization or biogenesis
aberrant cellular component organization
Deviation from the normal, usual, or expected events during organelle organization.
aberrant organelle organization and biogenesis
Deviation from the normal, usual, or expected events during cell adhesion.
OBSOLETE. Deviation from the normal, usual, or expected events during the response to DNA damaging agents.
obsolete aberrant response to DNA damaging agents
Deviation from the normal, usual, or expected events during release from spore dormancy.
Deviation from the normal, usual, or expected events during transport.
Deviation from the normal, usual, or expected events during cell projection biogenesis.
Deviation from the normal, usual, or expected events during bleb formation.
OBSOETE. Complete inability for chemotaxis during aggregation.
obsolete abolished chemotaxis during aggregation
Reduction in extent, amount, or degree of bleb assembly.
Increase in extent, amount, or degree of bleb assembly.
Increase in extend, amount, or degree of the number of tips in early culminant.
increased number of tip-organizers of the early culminant
increased number of early culminant tips
Increase in extend, amount, or degree of the number of mound tips.
increased number of tip-organizers of the tipped mound
Reduction in extent, amount, or degree of F-actin polymerization.
Complete inability to polymerize actin into F-actin.
OBSOLETE Reduction in extent, amount, or degree of activation of a protein kinase.
obsolete decreased protein kinase activation
OBSOLETE. Complete inability for chemotaxis to cAMP during aggregation.
obsolete abolished chemotaxis to cAMP during aggregation
OBSOLETE Increase in extent, amount, or degree of activation of protein kinases.
obsolete increased protein kinase activation
OBSOLETE Complete inability for activation of protein kinases.
obsolete abolished protein kinase activation
OBSOLETE. Complete inability for myosin light chain activation.
obsolete abolished myosin light chain kinase activation
OBSOLETE. Reduction in extent, amount or degree of myosin light chain kinase activation.
obsolete decreased myosin light chain kinase activation
OBSOLETE. Increase in extent, amount, or degree of myosin light chain kinase activation.
obsolete increased myosin light chain kinase activation
Deviation from the normal, usual, or expected morphology of the vacuole.
Deviation from the normal, usual, or expected events during cellular response to hyperosmotic stress.
aberrant cellular response to hyperosmotic stress
aberrant cellular response to hypertonic stress
Deviation from the normal, usual, or expected events during cellular response to hypo-osmotic stress.
aberrant cellular response to hypo-osmotic stress
aberrant cellular response to hypotonic stress
GO:0071476. For example, when Dictyostelium cells are placed into water, they suffer from hypotonic stress and their contractile vacuole system allows them to survive for some time.
Late onset or slower progression in the cellular response to hyperosmotic stress.
delayed cellular response to hyperosmotic stress
Early onset or faster progression in the response to cellular hyperosmotic stress.
precocious cellular response to hyperosmotic stress
precocious cellular hyperosmotic response
Early onset or faster progression in the cellular response to hypo-osmotic stress.
precocious cellular response to hypo-osmotic stress
precocious cellular response to hypotonic stress
Late onset or slower progression in the cellular response to hypo-osmotic stress.
delayed cellular response to hypo-osmotic stress
delayed cellular response to hypotonic stress
Deviation from the normal, usual, or expected events during the osmosensory signaling pathway.
Reduction in extent, amount, or degree of differentiation into prestalk A cells.
decreased prestalk A cell differentiation
Complete inability for differentiation of prestalk A cells.
abolished prestalk A cell differentiation
Deviation from the normal, usual, or expected events during slug migration.
Deviation from the normal, usual, or expected morphology of the mitochondrion.
OBSOLETE. Quantitative decrease in tubular mitochondria. In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete decreased number of tubular mitochondria
abolished aggregation during fruiting body development
abolished aggregation involved in sorocarp development
OBSOLETE. Quantitative decrease in spherical mitochondria.
In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete decreased number of spherical mitochondria
OBSOLETE. Quantitative increase in spherical mitochondria. In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete increased number of spherical mitochondria
OBSOLETE. Quantitative decrease in rod-shaped mitochondria. In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete decreased number of rod-shaped mitochondria
Deviation from the normal, usual, or expected events during vegetative growth.
OBSOLETE. Quantitative increase in rod-shaped mitochondria. In Dictyostelium, cells have mitochondria of three different shapes: spherical, rod-like or tubular.
obsolete increased number of rod-shaped mitochondria
Increase in extent, amount, or degree of chemotaxis in response to cAMP.
Increase in extent, amount, or degree of chemotaxis in response to folate.
increased positive chemotaxis to folic acid
Deviation from the normal, usual, or expected during the response to differentiation inducing factor 1.
aberrant response to differentiation inducing factor 1
Reduction in extent, amount, or degree of the response to DIF-1.
decreased response to differentiation inducing factor 1
Increase in extent, amount, or degree of response to DIF-1.
increased response to differentiation inducing factor 1
Complete inability for response to DIF-1.
abolished response to differentiation inducing factor 1
Late onset or slower progression in the response to DIF-1.
delayed response to differentiation inducing factor 1
Early onset or faster progression in the response to DIF-1.
precocious response to differentiation inducing factor 1
Deviation from the normal, usual, or expected in the DIF-1 biosynthesis.
aberrant differentiation inducing factor 1 biosynthesis
Reduction in extent, amount, or degree for DIF-1 biosynthesis.
decreased differentiation inducing factor 1 biosynthesis
Increase in extent, amount, or degree for DIF-1 biosynthesis.
increased differentiation inducing factor 1 biosynthesis
OBSOLETE. Late onset or slower progression for DIF production.
OBSOLETE. Complete inability for DIF production.
Complete inability for chemotaxis in response to cAMP.
Complete inability for chemotaxis in response to folate.
abolished positive chemotaxis to folic acid
Reduction in extent, amount, or degree of culminants, resulting in fewer fruiting bodies.
decreased culmination involved in sorocarp development
Increase in extent, amount, or degree of culminants, resulting in more fruiting bodies.
increased culmination involved in sorocarp development
Deviation from the normal, usual, or expected activity of a catalyst.
Reduction in extent, amount, or degree of lysosomal protein degradation.
decreased lysosomal protein catabolic process
Increase in extent, amount, or degree of lysosomal protein degradation.
increased lysosomal protein catabolic process
Deviation from the normal, usual, or expected events during the response to lithium.
Deviation from the normal, usual, or expected events during the response to valproic acid.
Deviation from the normal, usual, or expected events during exocytosis.
Reduction in extent, amount, or degree of exocytosis.
Increase in extent, amount, or degree of exocytosis.
Deviation from the normal, usual, or expected expression of genes.
aberrant expression of post aggregation-specific genes
merged_aberrant expression of aggregation genes
merged_aberrant expression of post-aggregative genes
Complete inability for expression of genes.
merged_abolished expression of post-aggregative genes
merged_abolished expression of prespore genes
Late onset or slower progression in the expression of genes.
merged_delayed expression of aggregation genes
merged_delayed expression of post-aggregative genes
merged_delayed expression of prespore genes
merged_delayed expression of prestalk genes
Early onset or faster progression in the expression of genes.
merged_precocious expression of aggregation genes
merged_precocious expression of post-aggregative genes
merged_precocious expression of prespore genes
merged_precocious expression of prestalk genes
OBSOLETE. Gene expression occurring in an abnormal position or in an unusual manner or form.
Deviation from the normal, usual, or expected events during signal transduction.
OBSOLETE Deviation from the normal, usual, or expected events during the regulation of protein kinase activity.
obsolete aberrant regulation of protein kinase activity
OBSOLETE. Complete inability for protein kinase B activation.
obsolete abolished protein kinase B activation
Deviation from the normal, usual, or expected events during the response to an external stimulus.
Deviation from the normal, usual, or expected events during the locomotory response to a chemical concentration gradient.
Increase in extent, amount, or degree of phototaxis.
Increase in extent, amount, or degree of thermotaxis.
Reduction in extent, amount, or degree of phototaxis.
Reduction in extent, amount, or degree of thermotaxis.
Increase in extent, amount, or degree of the response to an external stimulus.
Reduction in extent, amount, or degree of the response to external stimulus.
Complete inability to respond to an external stimulus.
OBSOLETE Reduction in extent, amount, or degree of activation of adenylate cyclase.
obsolete decreased activation of adenylate cyclase activity
OBSOLETE Complete inability to activate adenylate cyclase upon stimulus.
obsolete abolished activation of adenylate cyclase activity
OBSOLETE Increase in extent, amount, or degree of activation of adenylate cyclase.
obsolete increased activation of adenylate cyclase activity
OBSOLETE. Complete inability for chemoattractant-mediated F-actin polymerization.
obsolete abolished chemoattractant-mediated F-actin polymerization
OBSOLETE. Increase in extent, amount, or degree of chemoattractant-mediated F-actin polymerization.
obsolete increased chemoattractant-mediated F-actin polymerization
OBSOLETE Deviation from the normal, usual, or expected events during the regulation of the activity of a GTPase.
obsolete aberrant regulation of GTPase activity
OBSOLETE Reduction in extent, amount, or degree of positive regulation of GTPase activity.
obsolete decreased positive regulation of GTPase activity
IOBSOLETE Increase in extent, amount, or degree of positive regulation of GTPase activity.
obsolete increased positive regulation of GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of Ras GTPase activity.
obsolete aberrant regulation of Ras GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of Rac GTPase activity.
obsolete aberrant regulation of Rac GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of Rab GTPase activity.
obsolete aberrant regulation of Rab GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of Ran GTPase activity.
obsolete aberrant regulation of Ran GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of Rap GTPase activity.
obsolete aberrant regulation of Rap GTPase activity
OBSOLETE. Reduction in extent, amount or accumulation of positive regulation of Rab GTPase activity.
obsolete decreased positive regulation of Rab GTPase activity
OBSOLETE. Increase in extent, amount, or degree of positive regulation of Rab GTPase activity.
obsolete increased positive regulation of Rab GTPase activity
OBSOLETE. Reduction in extent, amount or accumulation of positive regulation of Rac GTPase activity.
obsolete decreased positive regulation of Rac GTPase activity
OBSOLETE. Increase in extent, amount, or degree of positive regulation of Rac GTPase activity.
obsolete increased positive regulation of Rac GTPase activity
OBSOLETE. Reduction in extent, amount or accumulation of positive regulation of Ran GTPase activity.
obsolete decreased positive regulation of Ran GTPase activity
OBSOLETE. Increase in extent, amount, or degree of positive regulation of Ran GTPase activity.
obsolete increased positive regulation of Ran GTPase activity
OBSOLETE. Reduction in extent, amount or accumulation of positive regulation of Rap GTPase activity.
obsolete decreased positive regulation of Rap GTPase activity
OBSOLETE. Increase in extent, amount, or degree of positive regulation of Rap GTPase activity.
obsolete increased positive regulation of Rap GTPase activity
OBSOLETE. Increase in extent, amount, or degree of positive regulation of Ras GTPase activity.
obsolete increased positive regulation of Ras GTPase activity
OBSOLETE. Reduction in extent, amount or accumulation of positive regulation of Ras GTPase activity.
obsolete decreased positive regulation of Ras GTPase activity
Deviation from the normal, usual, or expected events during macromolecule biosynthesis.
aberrant macromolecule biosynthetic process
Deviation from the normal, usual, or expected events during cellulose biosynthesis.
Complete inability for cellulose biosynthesis.
abolished cellulose biosynthetic process
Increase in extent, amount, or degree of cellulose biosynthesis.
increased cellulose biosynthetic process
Reduction in extent, amount, or degree of cellulose biosynthesis.
decreased cellulose biosynthetic process
Complete inability for superoxide generation.
Reduction in extent, amount, or degree of superoxide generation.
Increase in amount or generation of superoxide.
Deviation from the normal, usual, or expected events during differentiation of prestalk B cells.
aberrant prestalk B cell differentiation
Complete inability for differentiation of prestalk B cells.
abolished prestalk B cell differentiation
Reduction in extent, amount, or degree of differentiation into prestalk B cells.
decreased prestalk B cell differentiation
Increase in extent, amount, or degree of differentiation into prestalk B cells.
increased prestalk B cell differentiation
Deviation from the normal, usual, or expected events during the locomotory response to cAMP.
Deviation from the normal, usual, or expected events during the locomotory response to folate (folic acid).
aberrant positive chemotaxis to folic acid
Late onset or slower progression through cytokinesis.
Deviation from the normal, usual, or expected events during contractile ring contraction during mitotic cytokinesis.
aberrant cytokinesis, contractile ring contraction
aberrant mitotic actomyosin contractile ring contraction
Deviation from normal, usual, or expected molecular function.
Increase in extent, amount, or degree of guanyl-nucleotide exchange factor activity.
increased guanyl-nucleotide exchange factor activity
OBSOLETE. Deviation from the normal, usual, or expected events during aspidocyte differentiation.
obsolete aberrant aspidocyte differentiation
Increase in extent, amount, or degree of cell differentiation.
Decrease in extent, amount, or degree of cell differentiation.
Complete inability for cell differentiation.
Decrease in extent, amount, or degree of formation of pseudopods.
Reduction in relative or proportionate dimensions of the pseudopodium.
Reduction in extent, amount, or degree of F-actin polymerization in the area closest to the direction of movement in a motile cell.
decreased F-actin polymerization at leading edge
decreased actin filament polymerization at leading edge
Increase in extent, amount, or degree of F-actin polymerization in the area closest to the direction of movement in a motile cell.
increased F-actin polymerization at leading edge
increased actin filament polymerization at leading edge
Late onset or slower progression during pseudopodium formation.
Decrease in relative or proportionate dimensions of the spore.
Increase in relative or proportionate dimensions of the spore.
Decrease in amount or accumulation of intracellular myo-inositol.
Increase in amount or accumulation of intracellular myo-inositol.
Increase in amount or accumulation of intracellular 2,3-bisphosphoglycerate.
Reduction in amount or accumulation of intracellular 2,3-bisphosphoglycerate.
Reduction in extent, amount, or degree of macroautophagy.
Increase in extent, amount, or degree of macroautophagy.
Quantitative increase in autophagosomes.
Quantitative reduction in autophagosomes.
obsolete aberrant infection rate by a microorganism
obsolete increased infection rate by a microorganism
obsolete decreased infection rate by a microorganism
obsolete decreased infection rate by Mycobacterium avium
obsolete decreased infection rate by Cryptococcus neoformans
obsolete increased infection rate by Cryptococcus neoformans
OBSOLETE. Reduction in extent, amount, or degree of decreased actin-dependent ATPase activity.
obsolete decreased actin-dependent ATPase activity
OBSOLETE. Increase in extent, amount, or degree of increased actin-dependent ATPase activity.
obsolete increased actin-dependent ATPase activity
Reduction in amount or accumulation of actin filament sliding.
Increased in extent, amount, or degree of F-actin filament sliding.
Deviation from the normal, usual, or expected events during the response to nutrients.
Increase in relative or proportionate dimensions of the endosome.
Decrease in relative or proportionate dimensions of the endosome.
Deviation from the normal, usual, or expected morphology of the lysosome.
Decrease in relative or proportionate dimensions of the lysosome.
Increase in relative or proportionate dimensions of the lysosome.
Deviation from the normal, usual, or expected events during translation.
Reduction in extent, amount, or degree of translation.
Increase in extent, amount, or degree of translation.
Reduction in extent, amount, or degree of calcium-dependent cell-cell adhesion.
decreased calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
decreased EDTA-sensitive cell-cell adhesion
decreased calcium-dependent cell-cell adhesion
Reduction in extent, amount, or degree of calcium-independent cell-cell adhesion.
decreased calcium-independent cell-cell adhesion via plasma membrane cell adhesion molecules
decreased EDTA-resistant cell-cell adhesion
decreased calcium-independent cell-cell adhesion
Increase in extent, amount, or degree of calcium-dependent cell-cell adhesion.
increased calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
increased EDTA-sensitive cell-cell adhesion
increased calcium-dependent cell-cell adhesion
Increase in extent, amount, or degree of calcium-independent cell-cell adhesion.
increased calcium-independent cell-cell adhesion via plasma membrane cell adhesion molecules
increased EDTA-resistant cell-cell adhesion
increased calcium-independent cell-cell adhesion
Deviation from the normal, usual, or expected events during localization within the cell.
Deviation from the normal, usual, or expected localization of an organelle within the cell.
Deviation from the normal, usual, or expected localization of the Golgi apparatus.
Deviation from the normal, usual, or expected localization of the nucleus.
Deviation from the normal, usual, or expected localization of the centrosome.
Deviation from the normal, usual, or expected events during phagolysosome formation.
Reduction in extent, amount, or degree of phagolysosome formation.
Deviation from the normal, usual, or expected events during the locomotory response guided by increasing chemical concentration gradient.
Deviation from the normal, usual, or expected events during the locomotory response towards a decreasing chemical concentration.
Deviation from the normal, usual, or expected during the cellular response to extracellular stimulus.
aberrant cellular response to extracellular stimulus
OBSOLETE. Deviation from the normal, usual, or expected events during the response to prestarvation factor (PSF) found in conditioned media (CM).
obsolete aberrant response to prestarvation factor
OBSOLETE. Deviation from the normal, usual, or expected events during the detection of prestarvation factor (PSF) found in conditioned media (CM).
obsolete aberrant detection of prestarvation factor
Reduction in extent, amount, or degree of 3',5'-cyclic-AMP phosphodiesterase activity.
decreased cAMP-specific phosphodiesterase activity
decreased 3',5'-cyclic-AMP phosphodiesterase activity
Reduction in extent, amount, or degree of 3',5'-cyclic-GMP phosphodiesterase activity.
decreased cGMP-specific phosphodiesterase activity
decreased 3',5'-cyclic-GMP phosphodiesterase activity
Complete inability for protein secretion.
Increase in extent, amount, or degree of protein secretion.
Reduction in extent, amount, or degree of protein secretion.
Deviation from the normal, usual, or expected events during mitochondrion organization.
aberrant mitochondrion organization and biogenesis
Decrease in amount or accumulation of cytosolic ATP.
Increase in amount or accumulation of cytosolic ATP.
Deviation from the normal, usual, or expected events during lysosome organization and biogenesis.
aberrant lysosome organization and biogenesis
Deviation from the normal, usual, or expected events during post-lysosomal vacuole exocytosis.
aberrant post-lysosomal vacuole exocytosis
OBSOLETE. Reduction in extent, amount or degree of CRAC localization to the plasma membrane.
obsolete decreased CRAC localization to the plasma membrane
Deviation from the normal, usual, or expected level of proteins.
Reduction in extent, amount, or degree of protein expression.
Increase in extent, amount, or degree of protein expression.
Complete elimination of protein expression.
Deviation from the normal, usual, or expected events during cAMP signal oscillations in early development.
Complete inability for oscillatory cAMP signaling during early development.
OBSOLETE. Deviation from the normal, usual, or expected events during protein methylation.
OBSOLETE Complete inability for protein methylation.
abolished protein amino acid methylation
OBSOLETE Complete inability for C-terminal protein methylation.
obsolete abolished C-terminal protein methylation
Complete inability to establish cell polarity.
abolished establishment of cell polarity
obsolete increased protein kinase B activation
OBSOLETE. Complete inability for MAP activation.
obsolete abolished MAP kinase activation
OBSOLETE. Reduction in extent, amount or degree of MAP kinase activation.
obsolete decreased MAP kinase activation
OBSOLETE. Increase in extent, amount, or degree of activation of a MAP kinase.
obsolete increased MAP kinase activation
Deviation from the normal, usual, or expected binding.
Increase in extent, amount, or degree of catalysis by an enzyme.
Reduction in extent, amount, or degree of catalysis by an enzyme.
OBSOLETE. Reduction in extent, amount or degree of molecule binding.
Increased in extent, amount, or degree of binding to cAMP.
A reduction in extent, amount, or degree of binding to cAMP.
Deviation from the normal, usual, or expected events during the adaptation of a signaling pathway.
aberrant adaptation of signaling pathway
Deviation from the normal, usual, or expected events during autophagic cell death.
Complete inability for autophagic cell death.
Increase in extent, amount, or degree of autophagic cell death.
Reduction in extent, amount, or degree of autophagic cell death.
Deviation from the normal, usual, or expected events during regular cell death.
OBSOLETE. Deviation from the normal, usual, or expected events during non-apoptotic programmed cell death.
obsolete aberrant non-apoptotic programmed cell death
OBSOLETE. Complete inability for non-apoptotic programmed cell death.
obsolete abolished non-apoptotic programmed cell death
OBSOLETE. Increase in extent, amount, or degree of non-apoptotic programmed cell death.
obsolete increased non-apoptotic programmed cell death
OBSOLETE. Reduction in extent, amount or degree of non-apoptotic programmed cell death.
obsolete decreased non-apoptotic programmed cell death
Reduction in extent, amount, or degree of pseudopodium retraction.
Reduction in extent, amount, or degree of uropod retraction.
Deviation from the normal, usual, or expected events during engulfment of attached, recognized, external material.
Complete inability of engulfment of attached, recognized, external material.
abolished engulfment during phagocytosis
Reduction in extent, amount, or degree of engulfment of attached, recognized, external material.
decreased engulfment during phagocytosis
OBSOLETE. Deviation from the normal, usual, or expected events during vacuolation.
Reduction in extent, amount, or degree of autophagic vacuole formation.
decreased autophagic vacuole organization
Increase in extent, amount, or degree of 3',5'-cyclic-AMP phosphodiesterase activity.
increased cAMP-specific phosphodiesterase activity
increased 3',5'-cyclic-AMP phosphodiesterase activity
Increase in extent, amount, or degree of 3',5'-cyclic-GMP phosphodiesterase activity.
increased cGMP-specific phosphodiesterase activity>
increased 3',5'-cyclic-GMP phosphodiesterase activity
Increase in extent, amount, or degree of adenylate cyclase activity.
OBSOLETE. Reduction in extent, amount or degree of protein kinase A activity.
obsolete decreased protein kinase A activity
Reduction in extent, amount, or degree of guanyl-nucleotide exchange factor activity.
decreased guanyl-nucleotide exchange factor activity
Reduction in extent, amount, or degree of adenylate cyclase activity.
OBSOLETE. Increase in extent, amount, or degree of glycogen synthase kinase 3 activity.
obsolete increased glycogen synthase kinase 3 activity
Increase in extent, amount, or degree of guanylyl cyclase activity.
Reduction in extent, amount, or degree of guanylyl cyclase activity.
Complete absence of 3',5'-cyclic-AMP phosphodiesterase activity.
abolished 3',5'-cyclic-AMP phosphodiesterase activity
Complete absence of 3',5'-cyclic-GMP phosphodiesterase activity.
abolished 3',5'-cyclic-GMP phosphodiesterase activity
OBSOLETE. Complete absence of actin-dependent ATPase activity.
obsolete abolished actin-dependent ATPase activity
Complete absence of adenylate cyclase activity.
OBSOLETE. Complete inability for glycogen synthase kinase 3 activity.
obsolete abolished glycogen synthase kinase 3 activity
Complete absence of guanylyl cyclase activity.
OBSOLETE. Complete inability for GTP-gamma-S-stimulated guanylyl cyclase activity.
obsolete abolished GTP-gamma-S-stimulated guanylyl cyclase activity
Complete absence of lysosomal protein degradation.
abolished lysosomal protein catabolic process
OBSOLETE. Complete inability for protein kinase A activity.
obsolete abolished protein kinase A activity
Complete absence of guanyl-nucleotide exchange factor activity.
abolished guanyl-nucleotide exchange factor activity
OBSOLETE. Complete inability for protein kinase B activity.
obsolete abolished protein kinase B activity
OBSOLETE. Reduction in extent, amount ordegree of protein kinase B activity.
obsolete decreased protein kinase B activity
OBSOLETE. Increase in extent, amount, or degree of protein kinase B activity.
obsolete increased protein kinase B activity
OBSOLETE Deviation from the normal, usual, or expected events during the regulation of a catalytic activity.
obsolete aberrant regulation of catalytic activity
OBSOLETE Deviation from the normal, usual, or expected events during the regulation of the activity of adenylate cyclase.
obsolete aberrant regulation of adenylate cyclase activity
OBSOLETE. Complete inability to produce a cAMP pulse upon cAMP stimulation.
obsolete abolished cAMP-induced cAMP pulse
OBSOLETE. Complete inability for activation of of Rab GTPase activity.
obsolete abolished activation of Rab GTPase activity
OBSOLETE. Complete inability for activation of of Rac GTPase activity.
obsolete abolished activation of Rac GTPase activity
OBSOLETE. Complete inability for activation of of Ran GTPase activity.
obsolete abolished activation of Ran GTPase activity
OBSOLETE. Complete inability for activation of of Rap GTPase activity.
obsolete abolished activation of Rap GTPase activity
OBSOLETE Deviation from the normal, usual, or expected events during the activation of the activity of a GTPase.
obsolete aberrant activation of GTPase activity
OBSOLETE. Complete inability for activation of of Ras GTPase activity.
obsolete abolished activation of Ras GTPase activity
OBSOLETE. Deviation from the normal, usual, or expected events during peptidyl-proline 4-dioxygenase activity.
obsolete aberrant peptidyl-proline 4-dioxygenase activity
OBSOLETE. Reduction in extent, amount or degree of peptidyl-proline 4-dioxygenase activity.
obsolete decreased peptidyl-proline 4-dioxygenase activity
OBSOLETE Increase in extent, amount, or degree of peptidyl-proline 4-dioxygenase activity.
obsolete increased peptidyl-proline 4-dioxygenase activity
OBSOLETE. Complete inability for peptidyl-proline 4-dioxygenase activity.
obsolete abolished peptidyl-proline 4-dioxygenase activity
Deviation from the normal, usual, or expected during protein modification.
OBSOLETE Deviation from the normal, usual, or expected during peptidyl-proline modification.
obsolete aberrant peptidyl-proline modification
Increase in extent, amount, or degree of peptidyl-proline 4-dioxygenase activity.
increased peptidyl-proline 4-dioxygenase activity
Reduction in extent, amount, or degree of peptidyl-proline 4-dioxygenase activity.
decreased peptidyl-proline 4-dioxygenase activity
Deviation from the normal, usual, or expected peptidyl-proline 4-dioxygenase activity.
aberrant peptidyl-proline 4-dioxygenase activity
Complete absence of peptidyl-proline 4-dioxygenase activity.
abolished peptidyl-proline 4-dioxygenase activity
OBSOLETE Increase in level of hydroxylation of proline residues on a peptide.
obsolete increased peptidyl-proline hydroxylation
OBSOLETE Reduction in level of hydroxylation of proline residues on a peptide.
obsolete decreased peptidyl-proline hydroxylation
OBSOLETE Complete inability for peptidyl-proline hydroxylation.
obsolete abolished peptidyl-proline hydroxylation
Increase in level of modification of a protein.
Reduction in level of modification of a protein.
Complete inability for protein modification.
OBSOLETE. Reduction in extent, amount or accumulation of extracellular cAMP level.
obsolete decreased extracellular cAMP level
OBSOLETE. Increase in extent, amount, or degree of cAMP level.
obsolete increased extracellular cAMP level
Deviation from the normal, usual, or expected activity catalase.
Reduction in extent, amount, or degree of catalase activity.
Increase in extent, amount, or degree of catalase activity.
Deviation from the normal, usual, or expected events during localization of a protein from the cytoplasm to the plasma membrane.
aberrant localization to plasma membrane
aberrant protein localization to plasma membrane
Deviation from the normal, usual, or expected events during localization of a protein to the nucleus.
aberrant protein localization to nucleus
Increase in amount or accumulation of a protein at a certain location.
Reduction in amount or accumulation of a protein at a certain location.
Complete inability for secretion of lysosomal enzymes.
abolished secretion of lysosomal enzymes
Reduction in amount or accumulation of a protein in the nucleus.
decreased protein localization to nucleus
Increase in amount or accumulation of a protein in the nucleus.
increased protein localization to nucleus
OBSOLETE. Deviation from the normal, usual, or expected events during phosphorylation of a protein.
obsolete aberrant protein phosphorylation
OBSOLETE. Increase in amount or accumulation of phosphorylation of a protein.
obsolete increased protein phosphorylation
OBSOLETE. Reduction in amount or accumulation of phosphorylation of a protein.
obsolete decreased protein phosphorylation
OBSOLETE. Deviation from the normal, usual, or expected events during tyrosine phosphorylation of a protein.
obsolete aberrant protein tyrosine phosphorylation
OBSOLETE. Increase in amount or accumulation of tyrosine phosphorylation of a protein.
obsolete increased protein tyrosine phosphorylation
OBSOLETE. Reduction in amount or accumulation of threonine phosphorylation of a protein.
obsolete decreased protein threonine phosphorylation
OBSOLETE. Deviation from the normal, usual, or expected events during serine phosphorylation of a protein.
obsolete aberrant protein serine phosphorylation
OBSOLETE. Deviation from the normal, usual, or expected events during threonine phosphorylation of a protein.
obsolete aberrant protein threonine phosphorylation
OBSOLETE. Reduction in amount or accumulation of serine phosphorylation of a protein.
obsolete decreased protein serine phosphorylation
OBSOLETE. Increase in amount or accumulation of serine phosphorylation of a protein.
obsolete increased protein serine phosphorylation
OBSOLETE. Reduction in amount or accumulation of tyrosine phosphorylation of a protein.
obsolete decreased protein tyrosine phosphorylation
OBSOLETE. Increase in amount or accumulation of threonine phosphorylation of a protein.
obsolete increased protein threonine phosphorylation
Deviation from the normal, usual, or expected during the formation of the basal disc.
Reduction in relative or proportionate dimensions of the basal disc.
Deviation from the normal, usual, or expected during the formation of the outer basal disc.
Deviation from the normal, usual, or expected during the formation of the inner basal disc.
Complete absence of the outer basal disc.
Complete absence of the inner basal disc.
Reduction in relative or proportionate dimensions of the inner basal disc.
Reduction in relative or proportionate dimensions of the outer basal disc.
Increase in relative or proportionate dimensions of the inner basal disc.
Increase in relative or proportionate dimensions of the outer basal disc.
Deviation from the normal, usual, or expected morphology of the lower cup.
Deviation from the normal, usual, or expected morphology of the upper cup.
Complete inability to form an upper cup.
Increase in relative or proportionate dimensions of the lower cup.
Reduction in relative or proportionate dimensions of the lower cup.
Increase in relative or proportionate dimensions of the upper cup.
Reduction in relative or proportionate dimensions of the upper cup.
Reduction in extent, amount, or degree of chemotaxis in response to arachidonic acid.
decreased chemotaxis to arachidonic acid
Increase in extent, amount, or degree of chemotaxis in response to arachidonic acid.
increased chemotaxis to arachidonic acid
Deviation from the normal, usual, or expected events during cellular homeostasis.
Increase in amount or accumulation of intracellular glycogen.
increased regulation of intracellular pH
Reduction in amount or accumulation of ammonia.
OBSOLETE. Reduction in extent, amount or accumulation of extracellular glucose.
obsolete decreased extracellular glucose level
OBSOLETE. Increase in amount or accumulation of extracellular glucose.
obsolete increased extracellular glucose level
OBSOLETE. Reduction in extent, amount, or accumulation of extracellular pteridine level.
obsolete decreased extracellular pteridine level
Reduction in extent, amount, or degree of cytochrome C oxidase activity.
Increase in extent, amount, or degree of cytochrome C oxidase activity.
Complete absence of cytochrome C oxidase activity.
OBSOLETE. Deviation from the normal, usual, or expected events during CRAC localization to the plasma membrane.
obsolete aberrant CRAC localization to the plasma membrane
OBSOLETE. Increase in extent, amount, or degree of CRAC localization to the plasma membrane.
obsolete increased CRAC localization to the plasma membrane
Deviation from the normal, usual, or expected events during localization of a protein to the cytoplasm.
aberrant protein localization to cytoplasm
Increase in amount or accumulation of a protein in the cytoplasm.
increased protein localization to cytoplasm
Reduction in amount or accumulation of a protein in the cytoplasm.
decreased protein localization to cytoplasm
Complete inability to localize a protein to the cytoplasm.
abolished protein localization to cytoplasm
Complete inability to localize a protein to a cellular compartment or structure.
Use for the abolished localization of a protein that is affected by the mutation of another gene product.
Complete inability to localize a protein to the plasma membrane.
abolished localization to plasma membrane
abolished protein localization to plasma membrane
Reduction in the ability for localization of a protein from the cytoplasm to the plasma.
decreased localization to plasma membrane
decreased protein localization to plasma membrane
Increase in the ability for localization of a protein from the cytoplasm to the plasma membrane.
increased localization to plasma membrane
increased protein localization to plasma membrane
Extended duration for oscillatory cAMP signaling during early development.
Shortened duration for oscillatory cAMP signaling during early development.
Complete inability to localize a protein to the to microtubules.
abolished protein localization to microtubules
Complete inability to localize a protein to the microtubule organizing center.
abolished localization to microtubule organizing center
abolished protein localization to the MTOC
abolished protein localization to microtubule organizing center
Reduction in amount or accumulation of a protein to the microtubule organizing center.
decreased localization to microtubule organizing center
decreased protein localization to the MTOC
decreased protein localization to microtubule organizing center
Reduction in amount or accumulation of a protein at the microtubules.
decreased protein localization to microtubules
Increase in amount or accumulation of a protein at the microtubules.
increased protein localization to microtubules
Increase in amount or accumulation of a protein to the microtubule organizing center.
increased localization to microtubule organizing center
increased protein localization to the MTOC
increased protein localization to microtubule organizing center
Complete inability to localize a protein to coated pits.
abolished protein localization to coated pits
abolished protein localization to clathrin-coated pit
Reduction in amount or accumulation of a protein to coated pits.
decreased protein localization to coated pits
decreased protein localization to clathrin-coated pit
Increase in amount or accumulation of a protein to coated pits.
increased protein localization to coated pits
increased protein localization to clathrin-coated pit
Deviation from the normal, usual, or expected events during localization of a protein to coated pits.
aberrant protein localization to coated pits
aberrant protein localization to clathrin-coated pit
Complete absence of phosphatidylinositol binding.
Complete absence of phosphatidylinositol-4,5-bisphosphate binding.
abolished phosphatidylinositol-4,5-bisphosphate binding
OBSOLETE. Deviation from the normal, usual, or expected events during the response to conditioned medium factor (CMF) found in conditioned media (CM).
obsolete aberrant response to conditioned medium factor
Deviation from the normal, usual, or expected events during localization of a protein to pseudopodia.
aberrant protein localization to pseudopodium
Reduction in amount or accumulation of a protein in pseudopodia.
decreased protein localization to pseudopodium
Increase in amount or accumulation of a protein in pseudopodia.
increased protein localization to pseudopodium
Increase in relative or proportionate dimensions of the fruiting body.
Deviation from the normal, usual, or expected events during cell separation during cytokinesis.
aberrant cell separation during cytokinesis
Late onset or slower progression for cell separation during cytokinesis.
delayed cell separation during cytokinesis
Deviation from the normal, usual, or expected cell cycle event.
Deviation from the normal, usual, or expected during mitotic spindle organization.
Early onset or faster progression through mitotic spindle elongation.
OBSOLETE. Reduction in spindle stabilisation.
obsolete decreased spindle stabilisation
Deviation from the normal, usual, or expected events during mitotic sister chromosome segregation, resulting in an abnormal number of chromosomes.
aberrant mitotic sister chromatid segregation
Deviation from the normal, usual, or expected morphology of the nuclear envelope.
Deviation from the normal, usual, or expected morphology of the perinuclear space during nuclear membrane organization.
Deviation from the normal, usual, or expected events during centrosome organization.
Deviation from the normal, usual, or expected events during localization of a protein to the nuclear envelope.
aberrant localization to nuclear envelope
aberrant protein localization to nuclear envelope
Complete inability to localize a protein to the nuclear envelope.
abolished localization to nuclear envelope
abolished protein localization to nuclear envelope
Reduction in amount or accumulation of a protein at the nuclear envelope.
decreased localization to nuclear envelope
decreased protein localization to nuclear envelope
Increase in amount or accumulation of a protein in the nuclear envelope.
increased localization to nuclear envelope
increased protein localization to nuclear envelope
Deviation from the normal, usual, or expected events during development of tipped mound.
aberrant sorocarp development of tipped mound
Late onset or slower progression through spore formation.
Deviation from the normal, usual, or expected events during the gamma-aminobutyric acid signaling pathway.
aberrant gamma-aminobutyric acid signaling pathway
Complete absence of histone deacetylase activity.
Reduction in extent, amount, or degree of histone deacetylase activity.
Increase in extent, amount, or degree of histone deacetylase activity.
Deviation from the normal, usual, or expected events during programmed necrotic cell death.
Complete inability for programmed necrotic cell death.
abolished programmed necrotic cell death
Reduction in extent, amount, or degree of programmed necrotic cell death.
decreased programmed necrotic cell death
Increase in extent, amount, or degree of programmed necrotic cell death.
increased programmed necrotic cell death
OBSOLETE. Deviation from the normal, usual, or expected events when committing cells for a specific fate in their normal environment.
OBSOLETE. Reduction in extent, amount, or degree when committing cells for a specific fate in their normal environment.
Deviation from the normal, usual, or expected events when determining cells for a specific fate regardless of its environment.
Reduction in extent, amount, or degree when determining cells for a specific fate regardless of its environment.
Deviation from the normal, usual, or expected events during F-actin polymerization.
Deviation from the normal, usual, or expected events during F-actin depolymerization.
aberrant actin filament depolymerization
Complete inability to depolymerize actin into F-actin.
abolished actin filament depolymerization
Reduction in extent, amount, or degree of F-actin depolymerization.
decreased actin filament depolymerization
Increase in extent, amount, or degree of F-actin depolymerization.
increased actin filament depolymerization
OBSOLETE. Complete inability for protein phosphorylation.
obsolete abolished protein phosphorylation
OBSOLETE. Complete inability for actin phosphorylation.
obsolete abolished actin phosphorylation
OBSOLETE. Complete inability for protein serine phosphorylation.
obsolete abolished protein serine phosphorylation
OBSOLETE. Complete inability for protein threonine phosphorylation.
obsolete abolished protein threonine phosphorylation
OBSOLETE. Complete inability for protein tyrosine phosphorylation.
obsolete abolished protein tyrosine phosphorylation
Deviation from the normal, usual, or expected regulation of the intracellular pH.
Deviation from the normal, usual, or expected events during the response to cisplatin.
OBSOLETE. Deviation from the normal, usual, or expected events during DNA repair.
OBSOLETE. Deviation from the normal, usual, or expected events during double-strand break repair via homologous recombination.
obsolete aberrant double-strand break repair via homologous recombination
OBSOLETE. Reduction in extent, amount, or degree of double-strand break repair via homologous recombination.
obsolete decreased double-strand break repair via homologous recombination
OBSOLETE. Increase in amount or rate of double-strand break repair via homologous recombination.
obsolete increased double-strand break repair via homologous recombination
OBSOLETE. Deviation from the normal, usual, or expected events during chemotaxis to cAMP in response to DIF-1.
obsolete aberrant chemotaxis to cAMP in response to DIF-1
OBSOLETE. Deviation from the normal, usual, or expected events during chemotaxis to cAMP in response to DIF-2.
obsolete aberrant chemotaxis to cAMP in response to DIF-2
Deviation from the normal, usual, or expected events during the regulation of the locomotory response.
aberrant regulation of positive chemotaxis
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of chemotaxis to cAMP in response to DIF-1.
obsolete aberrant regulation of chemotaxis to cAMP in response to DIF-1
OBSOLETE. Deviation from the normal, usual, or expected events during regulation of chemotaxis to cAMP in response to DIF-2.
obsolete aberrant regulation of chemotaxis to cAMP in response to DIF-2
Deviation from the normal, usual, or expected events during microtubule nucleation.
Reduction in extent, amount, or degree of microtubule nucleation.
Increase in amount or rate of microtubule nucleation.
Deviation from the normal, usual, or expected events during centromere complex assembly.
Reduction in extent, amount, or degree of response to lithium.
Increase in extent, amount, or degree of response to lithium.
Deviation from the normal, usual, or expected events during inositol phosphate metabolism.
aberrant inositol phosphate metabolic process
Deviation from the normal, usual, or expected events during glucose catabolism.
OBSOLETE. Increase in amount or accumulation of intracellular 2,3-bisphosphoglycerate.
obsolete increased intracellular 2,3-bisphosphoglycerate
OBSOLETE Complete inability for methylation of histone H3 at lysine 79.
obsolete abolished histone H3-K79 methylation
OBSOLETE Complete inability for methylation of a lysine in histone H3.
obsolete abolished histone lysine methylation
OBSOLETE Complete inability for methylation of histone H3 at lysine 9.
obsolete abolished histone H3-K9 methylation
Complete inability of cell-cell adhesion.
Complete inability of calcium-dependent cell-cell adhesion.
abolished calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
abolished EDTA-sensitive cell-cell adhesion
abolished calcium-dependent cell-cell adhesion
Complete inability of calcium-independent cell-cell adhesion.
abolished calcium-independent cell-cell adhesion via plasma membrane cell adhesion molecules
abolished calcium-independent cell-cell adhesion
Deviation from the normal, usual, or expected events during organization of the actin cytoskeleton.
aberrant actin cytoskeleton organization
Deviation from the normal, usual, or expected events during organization of the cortical actin cytoskeleton.
aberrant cortical actin cytoskeleton stabilisation
aberrant cortical actin cytoskeleton organization
OBSOLETE. Deviation from the normal, usual, or expected events in the maintenance of the cortical actin cytoskeleton.
obsolete aberrant cortical actin cytoskeleton stabilisation
OBSOLETE. Deviation from the normal, usual, or expected during spindle stabilisation.
OBSOLETE. Increase in spindle stabilisation.
obsolete increased spindle stabilisation
Deviation from the normal, usual, or expected during mitotic spindle elongation.
Late onset or slower progression of the mitotic spindle elongation.
Deviation from the normal, usual, or expected events during phagosome maturation.
Complete inability for phagosome acidification.
Early onset or faster progression of phagosome acidification.
Late onset or slower progression of phagosome acidification.
Late onset or slower progression of phagosome reneutralization.
OBSOLETE. Deviation from the normal, usual, or expected events during mitochondrion distribution.
obsolete aberrant mitochondrion distribution
Deviation from the normal, usual, or expected events during intracellular distribution of mitochondria.
aberrant mitochondria positioning within cell
aberrant intracellular distribution of mitochondria
Reduction in relative or proportional dimensions of the phagolysosome.
Increase in relative or proportional dimensions of the phagolysosome.
Complete inability to localize a protein to the cell surface.
abolished protein localization to cell surface
Reduction in amount or accumulation of a protein on the cell surface.
decreased protein localization to cell surface
Increase in amount or accumulation of a protein to the cell surface.
increased protein localization to cell surface
Deviation from the normal, usual, or expected stabilization of proteins.
Reduction in extent, amount, or degree of protein stabilization.
Increase in extent, amount, or degree of protein stabilization.
Complete elimination of protein stabilization.
Deviation from the normal, usual, or expected events during the cellular response to cation stress.
aberrant cellular response to cation stress
Deviation from the normal, usual, or expected response triggered in response to the presence of a foreign body or the prevention/recovery from an infection.
OBSOLETE. Deviation from the normal, usual, or expected response to the presence of a microorganism that acts to protect the cell.
obsolete aberrant defence response to a microorganism
Deviation from the normal, usual, or expected events during localization of a protein to the cell cortex.
aberrant protein localization to cell cortex
Complete inability to localize a protein to the cell cortex.
abolished protein localization to cell cortex
Reduction in amount or accumulation of a protein to the cell cortex.
decreased protein localization to cell cortex
Increase in amount or accumulation of a protein to the cell cortex.
increased protein localization to cell cortex
Deviation from the normal, usual, or expected events during localization of a protein to the cell surface.
aberrant protein localization to cell surface
Complete inability to localize a protein pseudopodia.
abolished protein localization to pseudopodium
Deviation from the normal, usual, or expected events during localization of a protein to the microtubule organizing center.
aberrant localization to microtubule organizing center
aberrant protein localization to the MTOC
aberrant protein localization to microtubule organizing center
Deviation from the normal, usual, or expected events during localization of a protein to the microtubules.
aberrant protein localization to microtubules
Deviation from the normal, usual, or expected events during mitochondrial fusion.
Quantitative reduction of mitochondrial fusion.
Quantitative increase in mitochondrial fusion.
Deviation from the normal, usual, or expected events during mitochondrial fission.
Quantitative reduction of mitochondrial fission.
Quantitative increase in mitochondrial fission.
Deviation from the normal, usual, or expected events during the cellular response to fluid shear stress.
aberrant cellular response to mechanical stress
aberrant cellular response to fluid shear stress
OBSOLETE. Decreased tolerance of the normal, usual, or expected events during the cellular response to fluid shear stress.
obsolete decreased resistance to fluid shear stress
OBSOLETE. Increased tolerance of the normal, usual, or expected events during the cellular response to fluid shear stress.
obsolete increased resistance to fluid shear stress
Deviation from the normal, usual, or expected during chromatin assembly.
Increase in extent, amount, or degree of differentiation into prestalk U cells.
increased prestalk U cell differentiation
Reduction in extent, amount, or degree of differentiation into prestalk U cells.
decreased prestalk U cell differentiation
Deviation from the normal, usual, or expected events during differentiation of prestalk U cells.
aberrant prestalk U cell differentiation
Complete inability for differentiation of prestalk U cells.
abolished prestalk U cell differentiation
Deviation from the normal, usual, or expected events during the regulation of vegetative growth.
aberrant regulation of asexual reproduction
aberrant regulation of cell proliferation
aberrant regulation of vegetative growth
Deviation from the normal, usual, or expected events during the negative regulation of vegetative growth.
aberrant negative regulation of asexual reproduction
aberrant negative regulation of cell proliferation
aberrant negative regulation of vegetative growth
Complete inability to negatively regulate vegetative growth.
abolished negative regulation of asexual reproduction
abolished negative regulation of cell proliferation
abolished negative regulation of vegetative growth
Deviation from the normal, usual, or expected events during the positive regulation of vegetative growth.
aberrant positive regulation of asexual reproduction
aberrant positive regulation of cell proliferation
aberrant positive regulation of vegetative growth
Complete inability to positively regulate vegetative growth.
abolished positive regulation of asexual reproduction
abolished positive regulation of cell proliferation
abolished positive regulation of vegetative growth
Reduction in extent, amount, or degree of phagosomal protein processing.
decreased protein maturation by proteolysis in phagosome
decreased protein processing in phagocytic vesicle
Deviation from the normal, usual, or expected events during nucleus organization.
Phenotypes describing mutations in Dictyostelium.